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Rescue of ribosomes stalled on non-stop mRNAs is essential in bacteria and in the 
mitochondria of all eukaryotes. The lack of a stop codon causes ribosomes to stall at the 3’ 
end of mRNA with an empty A site, and specialized rescue mechanisms are required to release 
the truncated translation product and allow ribosome recycling. Of the known bacterial 
ribosome rescue systems, only ArfB has intrinsic peptidyl-tRNA hydrolysis activity, and is 
conserved in all eukaryotic mitochondria. The precise mechanism of ArfB-mediated ribosome 
rescue is not well understood.  
In this study, we use rapid kinetics in conjunction with FRET- and anisotropy-based methods 
to construct a detailed kinetic model for ArfB-mediated ribosome rescue. We find that ArfB 
binds to the ribosome rapidly regardless of mRNA length, and that the association rate for the 
majority of ArfB molecules in the ensemble is close to diffusion controlled. This is likely due to 
the flexibility of its unstructured C-terminal tail, which allows ArfB to associate with the 
ribosome in different orientations. A slow engagement step follows, which allows ArfB to 
discriminate between stalled ribosomes with and without mRNA extending past the P site. 
The engaged state of ArfB involves specific interactions that strongly increase the affinity of 
ArfB for the ribosome, and is the active state in which ArfB performs peptidyl-tRNA hydrolysis. 
ArfB dissociates slowly from the post-hydrolysis ribosome, which leads to a low turnover rate 
that can be increased somewhat by the presence of ribosome recycling factors. 
Cryo-electron microscopy structures of ArfB bound to two different substrates, one with 3’ 
mRNA extensions and one without, provide structural snapshots of ArfB-ribosome complexes 
along the rescue pathway. By superimposing the NMR structure of ArfB, in which the C-
terminal tail is unstructured, on the pre-hydrolysis stalled ribosome, we model possible initial 
binding complexes that support the kinetic data on multiple binding rates. The 2.6 Å structure 
of ArfB in the active state show an extensive network of specific interactions between ArfB 
and the ribosome, all of which involve residues that were previously found to be functionally 
important in a mutational study. These structures provide explanations for the high affinity 
and slow dissociation of ArfB. Our study demonstrates the role of intrinsic disorder in protein-






2.1 Bacterial protein synthesis 
Proteins are the main effectors of the biochemical reactions that underlie life, which include 
but are not restricted to signal transduction, catalysis, and movement. Protein synthesis 
represents the final step in the flow of genetic information that starts from DNA: nucleotide 
triplets, called codons, encode twenty commonly occurring amino acids, which are the 
building blocks of proteins. Sequences of amino acids in turn confer both three-dimensional 
structure and function to proteins. In the process of expressing a protein, the information 
stored in DNA is first transcribed into messenger RNA (mRNA), and finally converted into 
protein in a process termed translation. Efficient and accurate translation is essential to the 
growth and replication of the cell, and regulation of translation allows the cell to execute 
different genetic programs as well as rapidly respond to external stimuli. 
During translation, transfer RNAs (tRNA) carrying amino acids interact with mRNA via the 
anticodon, which base-pairs with the complementary codon on the mRNA. The growing 
peptide is thus transferred from one tRNA to the next by aminolysis and re-forming of the 
ester bond. In this way, tRNAs serve as the bridge between nucleotides and amino acids. The 
platform for this conversion of information is the ribosome, a large ribonucleoprotein complex 
that catalyzes peptide bond formation between amino acids. The ribosome facilitates 
translation through a dynamic and complex sequence of events, and along with a number of 
auxiliary translation factors, ensures the processivity and fidelity of translation.  
2.1.1 Ribosome structure 
The bacterial ribosome is a dynamic macromolecule consisting of two subunits: the 30S small 
subunit, which contains the 16S ribosomal RNA (rRNA) and 21 ribosomal proteins, and the 50S 
large subunit, which is composed of 5S rRNA, 23S rRNA, and 34 ribosomal proteins (reviewed 
in (Melnikov et al., 2012; Schmeing and Ramakrishnan, 2009)). 
The 30S subunit is home to the decoding center and the mRNA entry channel. Codon-
anticodon interactions take place in the decoding center, and the mRNA entry channel is the 
path of the mRNA through the ribosome during translation. The 50S subunit hosts the 




site of both peptide-bond formation and peptidyl-tRNA hydrolysis, and the peptide exit tunnel 
is occupied by the nascent peptide (Figure 2.1). 
Upon subunit joining, the interface between the subunits define the A, P, and E tRNA binding 
sites. The A site accommodates the incoming aminoacyl-tRNA, while the deacylated tRNA 
leaves the ribosome via the E site. The P site holds the peptidyl-tRNA, where the newly 
synthesized peptide is attached to the tRNA. 
 
Figure 2.1. Schematic of the 70S bacterial ribosome. The A-site tRNA is shown in purple. The 
P-site tRNA is shown in blue with the nascent peptide in orange. The mRNA is shown in green. 
The central importance of translation is reflected in the conservation of ribosome structure 
throughout different kingdoms of life. The functional core of the ribosome, in particular the 
decoding center and the peptidyl-transferase center, is made of structured RNA and does not 
vary much amongst different species (Melnikov et al., 2012). This allows us to infer the 
function of factors involved in translation based on homology. 
2.1.2 Initiation 
The first stage of translation is initiation. In this step, the ribosome recruits an mRNA and 
identifies the start codon (usually AUG in all kingdoms of life) that marks the beginning of a 
coding sequence. The most well-studied mode of initiation involves mRNAs that have a Shine-
Dalgarno sequence 8-10 nucleotides upstream of the start codon, and requires the initiation 
factors IF1, IF2, and IF3 (reviewed in (Milon and Rodnina, 2012)). 
In the first step of Shine-Dalgarno-led initiation, IF1, IF2, IF3, and the initiator tRNA fMet-
tRNAfMet are recruited to the small subunit, forming the 30S pre-initiation complex (PIC, Figure 




the last to bind, with fMet-tRNAfMet completing 30S PIC assembly by docking to IF2 (Milon et 
al., 2010; Milon et al., 2012).  
The 30S PIC becomes a stable 30S initiation complex after mRNA recruitment, when the Shine-
Dalgarno sequence interacts with the anti-Shine-Dalgarno sequence in the 16S rRNA of the 
30S subunit by complementary base-pairing (Figure 2.2b). Recognition of the start codon by 
the fMet-tRNAfMet anticodon triggers a conformational change in the 30S PIC and destabilizes 
IF3 binding (Milon et al., 2012). Finally, the large subunit docks on the 30S subunit. fMet-
tRNAfMet accommodates in the ribosomal P site after GTP hydrolysis by IF2, and dissociation 
of IF1 and IF2 allows intersubunit bridges to form, resulting in the mature 70S initiation 
complex (IC) (Goyal et al., 2015; Milon et al., 2008).  
 
Figure 2.2. Formation of the (a) 30S pre-initiation complex and the (b) 30S initiation complex 
(adapted from (Milon and Rodnina, 2012)). 
It is important to note that in bacteria, translation initiation is a co-transcriptional process; in 
other words, initiation occurs on mRNA that is still being transcribed (Rodnina, 2018). This is 
in stark contrast to eukaryotic initiation, where the transcript undergoes maturation that 
involves processing of the 3’ end and circularization before being translated (Wells et al., 1998). 
Proteins that bind to the 5’ 7-methylguanosine cap and to the 3’ poly(A) tail are involved in 
activating eukaryotic mRNAs for translation (reviewed in (Jackson et al., 2010)). In prokaryotes, 
however, the main determinant for translational efficiency lies in the ribosome binding site 
on the 5’ end of mRNA (Milon and Rodnina, 2012). According to the kinetic partitioning model, 




of the pathway (Figure 2.3). These features include the structure of the ribosome binding site, 
which affects the unfolding and association of the mRNA to the 30S PIC. The identity of the 
start codon, on the other hand, affects the strength of the codon-anticodon interaction in the 
30S IC (Milon and Rodnina, 2012). The sequence context around the ribosome binding site 
affects the conformation of the 30S IC, which in turn modulates the rate of large subunit 
association and 70S IC formation. Unlike in eukaryotes, the 3’ end of bacterial mRNAs is not 
monitored prior to initiation (Milon et al., 2008; Milon and Rodnina, 2012). 
 
Figure 2.3. mRNA selection by kinetic partitioning (Rodnina, 2016). 
2.1.3 Elongation 
Elongation, the repeated process of adding one amino acid at a time to the growing peptide 
chain, follows the initiation phase. Each amino acid is added in a cycle of decoding, peptide 
bond formation, and translocation. During decoding, elongation factor EF-Tu delivers 
aminoacyl-tRNA to the ribosome in a ternary complex with GTP, and the aminoacyl-tRNA with 
an anticodon complementary to the mRNA codon exposed in the ribosomal A site is selected 





Figure 2.4. Kinetic mechanism of decoding peptide bond formation (Rodnina et al., 2017). EF-
Tu is shown in blue, GTP in purple, GDP•Pi in red, and GDP-bound EF-Tu in pink. 
Correct codon-anticodon interactions in the A site trigger a conformational change in the 16S 
rRNA in the codon recognition step. Key residues in the decoding center are involved in this 
conformational change, namely A1492, A1493, and G530. A1492 and A1493 adopt a “flipped-
out” orientation, closing around the codon-anticodon complex, which also interacts with G530 
(Fischer et al., 2016; Loveland et al., 2017). Concurrently, the small subunit moves the ternary 
complex so that GTP hydrolysis by EF-Tu is activated (Fischer et al., 2016; Rodnina et al., 2017). 
The subsequent structural rearrangement of GDP-bound EF-Tu promotes the release of the 
aminoacyl-tRNA into the A site. At the codon recognition step and at the GTPase activation 
step, kinetic partitioning allows the ribosome to discriminate between cognate and non-
cognate aminoacyl-tRNAs (Rodnina et al., 2005). The accommodation of aminoacyl-tRNA into 
the A site further increases translation fidelity, because non-cognate aminoacyl-tRNAs 
accommodate at a slower rate (reviewed in (Rodnina et al., 2017)). 
Peptide bond formation occurs once the incoming aminoacyl-tRNA is accommodated in the A 
site. Formation of the peptide bond between two amino acids is catalyzed by the peptidyl-
transferase center, the active site of the ribosome which is almost entirely constituted of rRNA 




aminoacyl-tRNA on the carbonyl carbon of the ester bond in the P site peptidyl-tRNA (Figure 
2.5) (Rodnina, 2013). The ribosome ensures the correct positioning of rRNA and tRNA, and 
assists the reaction by ordering water molecules and by electrostatic shielding (Rodnina, 2013; 
Sharma et al., 2005; Wallin and Aqvist, 2010). 
 
Figure 2.5. Peptide bond formation reaction scheme (Rodnina, 2013). 
Once a new peptide bond is formed, the nascent peptide is transferred to the A-site tRNA. For 
another round of elongation to occur, the P-site tRNA must shift into the E site, and the A site 
tRNA must move into the P site, allowing ternary complexes carrying subsequent aminoacyl-
tRNAs to enter the A site (reviewed in (Dunkle and Cate, 2010; Rodnina et al., 2017; Rodnina 
and Wintermeyer, 2011)). The mRNA must also move by one codon so that the next codon is 
exposed in the A site. This is the process of translocation, which is promoted by the GTPase 
EF-G in concert with spontaneous movements of the ribosomal subunits in relation to each 
other (Figure 2.6) (Belardinelli et al., 2016). EF-G serves to destabilize interactions between 
the small subunit and the tRNA-mRNA complex, which allow the movement of the tRNA and 
mRNA by three nucleotides; it also provides the directionality of translocation so that the 
ribosome moves in the 5’ to 3’ direction with respect to the mRNA. Through interactions 
between EF-G and the P site tRNA, and by accelerating movements of the ribosome, EF-G 
ensures that the ribosome remains in the same reading frame throughout translocation (Peng 







Figure 2.6. Kinetic scheme of translocation. GTP-bound EF-G is shown in pink, GDP•Pi-bound 
EF-G is shown in red, and GDP-bound EF-G is shown in yellow. The 30S subunit goes from a 
locked (gray) state to an unlocked (green) state (Rodnina et al., 2011). 
2.1.4 Termination 
When the ribosome reaches the end of an open reading frame, the fully translated nascent 
peptide must be released from the P-site tRNA and allowed to dissociate from the ribosome. 
Under normal conditions, a stop codon is presented in the A site which can be recognized by 
canonical release factors RF1 and RF2. RF1 recognizes UAA and UAG, while RF2 recognizes 
UAA and UGA (reviewed in (Korostelev, 2011)). Following recognition of the stop codon, 
release factors catalyze hydrolysis of the peptidyl-tRNA bond in the peptidy-transferase center. 
RF3 then assists the dissociation of release factors from the ribosome (Figure 2.7) (reviewed 
in (Dunkle and Cate, 2010; Korostelev, 2011).  
 
Figure 2.7.Dynamic model of bacterial translation termination. RF1 is shown in green and RF3 
is shown in fuchsia. Red arrows represent rapid reactions, blue arrows represent slow 
conversion, and single-headed arrows represent irreversible peptide hydrolysis. The 




Stop codon recognition during termination is performed by domains 2, 3 and 4 of the release 
factors, which contain the PxT motif of RF1, and the SPF motif of RF2 (Figure 2.8). Structural 
studies have revealed interactions between the release factors and each individual nucleotide 
of the stop codon: helix α5 recognizes the first invariant uracil, while residues in the PxT motif 
and the SPF motif recognize the second nucleotide. The third and final residue of the stop 
codon is read by conserved residues in the recognition loop that contains the PxT/SPF motifs 
(Korostelev et al., 2010; Laurberg et al., 2008). 
Upon stop codon recognition, the release factors undergo a conformational rearrangement, 
with the switch loop interacting with the universally conserved decoding center residues 
A1492, A1493, and G530 in 16S rRNA, as well as A1913 in 23S rRNA (Jin et al., 2010; Korostelev 
et al., 2008; Laurberg et al., 2008; Weixlbaumer et al., 2008). These interactions stabilize the 
release factor in a catalytically active conformation, positioning the conserved GGQ motif of 
domain 3 in the peptidyl-transferase center. In this way, the catalytic activity of release factors 
is contingent on stop codon recognition, preventing premature termination of translation. 
 
Figure 2.8. Crystal structures of (a) RF1 and (b) RF2. Individual domains are numbered 
(adapted from (Korostelev, 2011)). 
Peptidyl-tRNA hydrolysis is the second reaction catalyzed by the peptidyl-transferase center, 
the first being peptide bond formation. Hydrolysis takes place as a nucleophilic attack by a 
water molecule or a hydroxide ion (Kuhlenkoetter et al., 2011). As a result, the reaction is 
highly dependent on the pH of the solution (Indrisiunaite et al., 2015; Kuhlenkoetter et al., 
2011). The GGQ motif of release factors is directly involved in peptidyl-tRNA hydrolysis; it 
reaches into the peptidyl-transferase center and contacts nucleotides of the 23S rRNA and the 




rRNA are in positions analogous to when the 50S A site binding pocket is occupied by 
aminoacyl-tRNA (Jin et al., 2010; Korostelev et al., 2008; Laurberg et al., 2008; Weixlbaumer 
et al., 2008). The exact role of the GGQ motif in catalysis is not yet clear, however evidence 
suggests that the backbone NH group of the glutamine residue stabilizes the tetrahedral 
transition state intermediate and the leaving group (Figure 2.9) (Laurberg et al., 2008). The 
two glycine residues appear to facilitate the optimal positioning of the glutamine residue. 
Interestingly, the GGQ motif of both RF1 and RF2 have been shown to be methylated by HemK 
in vivo (Mora et al., 2007; Nakahigashi et al., 2002). The role of the methylation appears to 
contribute to the binding affinity of the release factor, and increases the rate of hydrolysis up 
to 10 fold so that all amino acids are hydrolyzed at a uniform rate (Pierson et al., 2016). It is 
worth noting that while release factors are not conserved, the GGQ motif is universally 
conserved (Dunkle and Cate, 2010). It can therefore be inferred that the catalytic mechanism 
of release factor-induced peptidyl-tRNA hydrolysis in the peptidyl-transferase center is similar 
between prokaryotes and eukaryotes. 
 
Figure 2.9. Stabilization of the tetrahedral transition state intermediate (purple) and the 
leaving group (orange) by the GGQ motif (green) (Korostelev, 2011). 
After the nascent peptide is released, release factors need to dissociate from the ribosome. 
RF2 can dissociate from the post-termination ribosome spontaneously, whereas RF1 cannot 
(Peske et al., 2014; Zaher and Green, 2011). Dissociation of both factors is facilitated by the 
translational GTPase RF3 (Zavialov et al., 2001). RF3 can bind to the release factor-bound 
ribosome, and binding is stabilized upon peptide release, promoting dissociation of the 
release factor. GTP hydrolysis then promotes RF3 dissociation. Recent studies have shown that 
the ribosome undergoes a complex landscape of dynamics during termination, with each 






The final step in translation is the recycling of the ribosomal subunits, which frees them to 
undergo initiation and perform further rounds of translation. In bacteria, this is mediated by 
translation factors RRF, EF-G, and IF3. Key events that occur during recycling include the 
dissociation of tRNA and mRNA, and the splitting of the ribosome into individual subunits 
(reviewed in (Rodnina, 2018)). 
It has been shown that effective EF-G binding occurs when RRF is bound to the post-
termination ribosome (Borg et al., 2016), and that IF3 promotes tRNA dissociation and 
prevents the individual subunits from re-associating before 70S IC formation (Rodnina, 2018). 
However the exact sequence of recycling events is still a matter of debate, in particular with 
regards to the timing of mRNA dissociation. In one model, EF-G hydrolyzes GTP, and the Pi 
(inorganic phosphate) release splits the ribosome with the tRNA and mRNA still attached to 
the small subunit (Figure 2.10). IF3 then displaces the tRNA and the mRNA dissociates 
spontaneously (Borg et al., 2016; Fu et al., 2016; Peske et al., 2005; Rodnina et al., 1997; Seo 
et al., 2004). Another model suggests that EF-G promotes mRNA release by GTP hydrolysis 
(Chen et al., 2017). 
 
Figure 2.10. A model of ribosome recycling. RRF (blue) and GTP-bound EF-G (pink) bind to the 
post-termination ribosome. GTP-hydrolysis (GDP•Pi-bound EF-G is shown in red) and Pi 
release (GDP-bound EF-G is shown in yellow) promote ribosome splitting (Rodnina et al., 2011). 
Recycling marks the end of one round of protein synthesis, and ensures the availability of 
ribosomal subunits. However, during each stage of translation, a number of events can occur 
that cause the ribosome to pause or completely stall on mRNA, effectively rendering them 
inactive. This is highly detrimental to cell viability (Chadani et al., 2011b; Feaga et al., 2016), 
not least because ribosome biogenesis is energetically costly (Davis and Williamson, 2017). 





2.2 Ribosome pausing and arrest 
The speed and progression of translation is modulated by many intrinsic factors, including 
mRNA secondary structures, poly-proline stretches, stalling peptides, and codon usage 
(reviewed in (Buskirk and Green, 2017; Rodnina, 2016)). Some of these factors provide 
opportunities to regulate the synthesis of specific proteins and thereby maintain homeostasis; 
for example, mRNA secondary structures can influence the kinetics of mRNA selection during 
translation initiation, resulting in different expression levels between transcripts (Reeve et al., 
2014). Furthermore, codon usage affects translation kinetics on stretches of the same 
transcript, because the cellular concentration of different tRNA isoforms is different 
(Gorochowski et al., 2015; Tuller et al., 2010). This has been shown to allow the nascent 
peptide to assume the correct fold co-translationally (Buhr et al., 2016; Yu et al., 2015). In 
some other cases, the ribosome pauses altogether. For example, the SecM stalling peptide 
regulates the copy number of certain membrane proteins (Nakatogawa et al., 2004). Pausing 
in this situation can be resolved, and translation can continue on the same transcript.  
There are also cases where ribosomes are stalled in response to stress conditions. The 
accumulation of these stalled ribosomes is unproductive, and require termination of 
translation altogether for the ribosome to engage in productive rounds of protein synthesis. 
This can happen during the bacterial stress response or because of mRNA damage (reviewed 
in (Starosta et al., 2014)). Termination on these stalled ribosomes results in a ribosome free 
to undergo initiation, as well as the release of an unfinished translation product. In the 
following section, examples of pausing resolved by continued elongation and of stalling 
resolved by premature termination are discussed. 
2.2.1 Ribosome pausing resolved by elongation 
The availability of aminoacylated tRNAs is a key element effecting elongation rates. In bacteria, 
this plays a role in attenuation of gene expression: operons encoding genes involved in amino 
acid biosynthesis often have a segment in the 5’ end of the open reading frame containing 
codons for the amino acid regulated by that operon (Yanofsky, 1981). Scarcity of the amino 
acid in question leads to fewer aminoacyl-tRNAs that correspond to those codons, leading to 
ribosomes pausing. Translational pausing allows secondary structures to form downstream of 
the paused ribosome, which eliminates a transcription termination signal, allowing the 




characteristics have been identified in operons for the biosynthesis of tryptophan, histidine, 
threonine, isoleucine, leucine, and phenylalanine. Upon biosynthesis of the amino acid, the 
paused ribosome can resume translation, triggering transcription termination downstream 
and reducing production of amino acid biosynthesis components (reviewed in (Kolter and 
Yanofsky, 1982)). 
Ribosomes also pause on mRNAs encoding consecutive proline residues. Proline is a secondary 
amine, making it a poor peptidyl acceptor; its cyclic side chain affects the positioning of Pro-
tRNAPro in the peptidyl-transferase center, making it also a poor peptidyl-donor (Doerfel et al., 
2015). To resolve pausing on poly-proline stretches, the ribosome employs the dedicated 
factor EF-P (Doerfel et al., 2013). Structural studies have shown that EF-P binds between the 
ribosomal P site and E site and interacts with the CCA end of the P-site tRNA (Figure 2.11) 
(Huter et al., 2017a). Kinetic studies revealed that this interaction serves to steer the P site 
and A site tRNAs into an orientation more favorable for the peptidyl-transfer reaction (Doerfel 
et al., 2015). 
 
Figure 2.11. Schematic (left) and structural model (right) of EF-P bound to a ribosome stalled 
on a poly-proline sequence (prolines are indicated as red stars) (adapted from (Huter et al., 
2017a)). 
Finally, certain nascent peptide sequences also pause translation. The SecM peptide causes 
stalling during elongation on an RxGP motif, which is due to distortions in the peptidyl-
transferase center caused by interactions with rRNA residues in the peptide exit tunnel (Figure 
2.12) (Bhushan et al., 2011; Gumbart et al., 2012). The resulting stalled ribosomal complexes 
are very stable. The stalling is relieved by SecA, a protein encoded downstream of SecM. It has 




proceed (Bhushan et al., 2011; Gumbart et al., 2012). This is an elegant mechanism to maintain 
the stoichiometry of bacterial secretion machinery: the Shine-Dalgarno sequence of SecA is 
exposed as a consequence of SecM stalling, and an abundance of SecA relieves SecM stalling 
which in turn downregulates SecA expression (Nakatogawa et al., 2004). Another example is 
the TnaC peptide, which is encoded upstream of genes tryptophanase and tryptophan 
permease genes. When tryptophan is abundant in the cell, free tryptophan binds to the 
ribosome and inhibits TnaC release by RF2 (Gong and Yanofsky, 2002; Martinez et al., 2014). 
This stalling prevents Rho-dependent transcription termination and results in expression of 
the downstream genes that facilitate breakdown of tryptophan. At low cellular tryptophan 
levels, translation termination can proceed on the TnaC peptide unimpeded. 
 
Figure 2.12. SecM (green) stalls the ribosome via interactions with the peptide exit tunnel 
(grey) (Bhushan et al., 2011). 
One key similarity between proline-induced stalling and nascent peptide-induced stalling is 
the occupancy of the ribosomal A site. When the ribosome stalls on consecutive proline 
residues, the ribosomal A site is occupied by a Pro-tRNAPro (Huter et al., 2017a); the same can 
be said for SecM-induced stalling (Bhushan et al., 2011). On the other hand, ribosomes stalled 




presence of either aminoacyl-tRNA or release factor ensures that these stalled ribosomes are 
not targeted for rescue by premature termination (Buskirk and Green, 2017). 
2.2.2 Ribosome stalling resolved by premature termination 
In the previous section, reversible instances of ribosome stalling are described. These cases 
are reversible in the sense that binding of an aminoacyl-tRNA or action of another protein 
factor relieves stalling and allows the ribosome to complete elongation and termination on an 
otherwise undamaged transcript (Buskirk and Green, 2017). In other instances, the ribosome 
can translate until the 3’ end of the mRNA and stall due to the lack of an in-frame stop codon, 
resulting in a stalled ribosome that has an unoccupied A site. To resolve these non-stop stalled 
ribosomal complexes, premature termination allows the ribosome to be recycled while 
releasing an incompletely synthesized translation product (reviewed in (Starosta et al., 2014)). 
Non-stop stalling can be caused by errors in decoding. Stop codon read-through, where the 
ribosome fails to decode the stop codon and continues translating into the 3’UTR of the 
transcript, has been shown to produce non-stop stalled ribosomes, for example when 
suppressor tRNAs that decode stop codons are expressed (Ueda et al., 2002). Aminoglycoside 
antibiotics bind to the 16S rRNA of the 30S subunit and interfere with the function of the 
decoding center (reviewed in (McCoy et al., 2011)). They often induce decoding errors that 
can lead to stop codon read-through or loss of the correct reading frame, moving the stop 
codon out of frame and thereby creating non-stop stalled ribosomes (Abo et al., 2002; 
Holberger and Hayes, 2009). 
Another cause of non-stop stalling is the truncation of mRNAs. The lack of mRNA surveillance 
in bacteria, particularly mechanisms that monitor the 3’ end of mRNAs, means that the 
ribosome cannot avoid initiating on damaged transcripts, as is discussed in section 2.1.2. In 
bacteria, mRNA turnover is mediated by 3’-5’ cleavage by the exoribonuclease RNase II 
(Deutscher and Reuven, 1991), but this is commonly preceded by endonucleolytic cleavage in 
the 5’ end of transcripts mediated by RNase E (Hui et al., 2014). Because translation initiation 
depends on sequence featured in the 5’ UTR of mRNA, it is unlikely that regular mRNA 
turnover contributes significantly to non-stop stalling.  
One source of truncated mRNAs is premature transcription termination. One example is the 




thereby repressing transcription of the lacZYA gene. At high levels of LacI, it will also bind to a 
third operator site at the 3’ end of the lacI gene itself, inducing premature transcription 
termination and regulating its own expression (Abo et al., 2000). Because translation in 
bacteria occurs co-transcriptionally, this can occur while there are translating ribosomes on 
the growing lacI transcript, and results in non-stop stalled ribosomes. Similar modes of 
transcription regulation have been identified in other organisms, for example the catabolite 
control protein CcpA in B. subtilis (Ujiie et al., 2009).  
Furthermore, some early studies have suggested that translational pausing can lead to 
cleavage of the codon in the ribosomal A site (Hayes and Sauer, 2003; Sunohara et al., 2004). 
This has been observed in the context of consecutive proline residues, where both peptide 
bond formation and peptide release are slow (Hayes et al., 2002a; Roche and Sauer, 2001). 
Similarly, ribosomes stalled at rare codons were found to go through A-site mRNA cleavage 
(Hayes et al., 2002b; Roche and Sauer, 1999); these studies deal in particular with consecutive 
rare arginine codons. It should be mentioned that in most of these studies, mRNA truncation 
was inferred by studying SsrA-tagging, a product of tmRNA-SmpB mediated ribosome rescue 
that will be discussed in a later section. The mechanism of A-site mRNA cleavage is unclear; 
studies have found that in the absence of mRNA interferases such as RelE, MazF, ChpBK, YoeB, 
YafQ, and YhaV, ribosome pausing-induced mRNA cleavage is still observed (Garza-Sanchez et 
al., 2009; Hayes and Sauer, 2003). It has been proposed that RNase II plays a role, however 
further cleavage of the transcript in the ribosomal A site is required for SsrA-tagging (Garza-
Sanchez et al., 2009), pointing to the involvement of other mRNA interferases. 
2.2.3 mRNA truncation by toxin-antitoxin systems 
An important source of truncated mRNAs is through the action of bacterial toxin-antitoxin 
systems. The toxin is usually a globular protein, the activity of which is inhibited when the 
labile antitoxin protein wraps around it. The two proteins are often encoded together on a 
plasmid or in the bacterial chromosome, so that the toxin is constitutively bound by the 
antitoxin and therefore inactive.  The antitoxin is degraded under specific conditions such as 
stress, which frees the toxin to take part in the stress response (reviewed in (Yamaguchi et al., 
2011)). It has been proposed that toxin-antitoxin systems function in programmed cell death 
(Gerdes et al., 1997) and nutritional stress (Gerdes, 2000). There are several types of toxin-




truncated mRNAs in response to certain stress conditions (reviewed in (Starosta et al., 2014)). 
In this section, mRNA interferases, or type II toxin-antitoxin systems that cleave mRNAs, are 
discussed. 
The MazEF toxin-antitoxin system differs from other mRNA interferases in that it cleaves 
mRNA independently of the ribosome. The toxin MazF cleaves mRNA at 3-, 5-, and 7- 
nucleotide motifs (Cook et al., 2013), and is inactivated by the antitoxin MazE, which blocks 
the mRNA binding site on MazF (Figure 2.13a) (Simanshu et al., 2013). Degradation of MazE is 
triggered by heat stress, starvation, oxidative stress, DNA damage (Hazan et al., 2004). Some 
studies have found that MazEF cleaves ACA sequences upstream of start codons (Figure 2.13b), 
effectively creating leaderless mRNAs (Vesper et al., 2011). Concurrently, it was suggested 
that MaxF cleavage also targets the ribosomal 16S rRNA, which removes the anit-Shine-
Dalgarno sequence (Moll and Engelberg-Kulka, 2012). These findings led to the hypothesis 
that MazF activates an alternative translation program in which specialized ribosomes 
translate leaderless mRNAs. However, a subsequent study used ribosome profiling to 
construct a global analysis of MaxF-mediated mRNA cleavage, and found no preference for 
either the 5’ UTR or the anti-Shine-Dalgarno sequence (Culviner and Laub, 2018). It was 
instead proposed that MazF reduces overall translation activity by cleaving multiple sites in 
mRNA, and by targeting transcripts encoding ribosomal proteins as well as rRNA. Notably, 
Culviner and colleagues also found that ribosome footprints increased by ~8 fold on the 
mRNA-like domain of tmRNA, indicating that MazF activity produces non-stop stalled 
ribosomes that require rescue by tmRNA-SmpB. 
 
Figure 2.13. Structure of Bacillus subtilis toxin MazF dimers (cyan and red) (a) in complex with 
the antitoxin MazE (blue and purple) and (b) bound to the target mRNA sequence (yellow) 




In contrast to the MazEF system, the RelBE toxin-antitoxin system is ribosome-dependent. The 
mRNA cleavage activity of RelE is only active when RelE is bound to the ribosome (Pedersen 
et al., 2003). To inactivate RelE, RelB wraps around the toxin (Figure 2.14a), reaching into the 
active site and at the same time preventing RelE from entering the ribosomal A site (Boggild 
et al., 2012; Neubauer et al., 2009). RelE is believed to be activated in response to amino acid 
starvation (Christensen et al., 2001; Pedersen et al., 2002), upon which Lon protease digests 
the antitoxin RelB, freeing RelE to bind to ribosomes stalled with an unoccupied A site 
(Christensen et al., 2001; Neubauer et al., 2009) (Figure 2.14c). In previous studies, it was 
proposed that RelBE targets the stop codons UAG and UGA, as well as the sense codons UCG 
and CAG (Pedersen et al., 2003). However, a more recent ribosome profiling study, RelBE was 
found to have a general preference for cleavage after C and before G (Buskirk and Green, 
2017). The same study also revealed that RelE cleavage most often occurs after the second 
codon of in the vacant A site, leaving ribosomes stalled with two nucleotides extending past 
the ribosomal P site (Buskirk and Green, 2017). RelE activity stops translation in its tracks, 
allowing the cell to divert resources towards pathways that overcome stress. Resolving the 
resulting non-stop stalled ribosomes, however, requires the action of rescue mechanisms. 
 
Figure 2.14. Structure of the E. coli toxin RelE (a) in complex with the antitoxin RelB, (b) bound 
to mRNA, and (c) bound to the A site of the 70S ribosome (adapted from (Starosta et al., 2014)). 
Other ribosome-dependent type II toxin-antitoxin systems in E. coli include YefM/YeoB, 
DinJ/YafQ, YafNO, and YgjNM, most of which are also activated by amino-acid starvation 
(reviewed in (Starosta et al., 2014)). Like RelE, YoeB catalyzes the cleavage of mRNA in the 
ribosomal A site in the absence of YefM (Feng et al., 2013). A recent study proposed that YoeB 
is activated during heat shock, although global protein synthesis is not inhibited by YoeB-
induced mRNA cleavage (Janssen et al., 2015). The authors therefore argue that instead of 




digest the associated transcript, effectively creating more ideal substrates for ribosome rescue 
mechanisms so that the ribosomes can be recycled. The YafQ toxin in the DinJ/YafQ toxin-
antitoxin system, on the other hand, binds to the 50S subunit of the ribosome and cleaves 
mRNA. It is believed that the antitoxin DinJ is degraded in response to DNA damage (Armalyte 
et al., 2012; Prysak et al., 2009). 
2.2.4 Beyond non-stop stalling 
Stalling of the 70S ribosome has thus far been discussed. However, it has been shown that 
heat shock in bacteria causes translating ribosomes to dissociate into the 30S subunit and the 
peptidyl-tRNA-bound 50S subunit (Korber et al., 2000). For these 50S subunits to participate 
in translation initiation, the peptidyl-tRNA must be hydrolyzed. It has been proposed that the 
protein Hsp15, which is upregulated upon heat shock, plays a role in the rescue of these 
subunits (Jiang et al., 2009). Hsp15 interacts with both the 23S rRNA and with the peptidyl-
tRNA, stabilizing the peptidyl-tRNA in the P site (Jiang et al., 2009). This allows the A site to 
remain vacant. Jiang and colleagues postulated that factors with peptidyl-tRNA hydrolysis 
activity can then bind to the A site and release the nascent peptide (Figure 2.15). Given that 
canonical release factor activity is contingent on stop codon recognition (Jin et al., 2010; 
Korostelev et al., 2008; Laurberg et al., 2008; Weixlbaumer et al., 2008), it was proposed that 
hydrolysis could be catalyzed by stop codon-independent release factors such as ArfB (Jiang 
et al., 2009). 
 
Figure 2.15. Model of peptidyl-tRNA (pink) translocation mediated by Hsp15 (green). The 
vacated ribosomal A site is a potential binding site for rescue factors or release factors that 




2.3 Rescue mechanisms for non-stop stalling 
The rescue of non-stop stalled ribosomes requires hydrolysis of the peptidyl-tRNA in the P site, 
after which the ribosome recycling machinery (described in section 2.1.5) can recycle the 
ribosomal subunits for subsequent rounds of translation. In bacteria, this is accomplished in 
two ways: rescue factors tmRNA-SmpB (the components of the trans-translation pathway) 
(Figure 2.16a) and ArfA (Figure 2.16b) effectively serve as interfaces between the stalled 
ribosome and canonical release factors, either by introducing a stop codon (tmRNA-SmpB) 
(Keiler et al., 1996), or by facilitating release factor binding (ArfA) (Chadani et al., 2010). 
Alternatively, ArfB (Figure 2.16c) is a peptidyl-tRNA hydrolase that acts as a stop codon-
independent release factor (Chadani et al., 2011b; Handa et al., 2011). 
It has been reported that in E. coli, 0.4% of all synthesized peptides are tagged with the ssrA 
degradation tag of the tmRNA-SmpB system (Moore and Sauer, 2005). More recently, analysis 
of nascent polypeptides showed that an estimated 2-4% of translation events result in non-
stop stalling (Ito et al., 2011). It appears that non-stop stalling is a common occurrence in the 
cell, and recue mechanisms play an important role in maintaining the cell’s capacity for protein 
synthesis.  
 
Figure 2.16. Three rescue mechanisms for non-stop stalled ribosomes in E. coli: (a) tmRNA-





Trans-translation is the most well-studied bacterial rescue mechanism for resolving non-stop 
stalled ribosomal complexes. It involves restarting translation by switching from the truncated 
mRNA template to the coding sequence on the tmRNA molecule, which ends with a stop 
codon that allows translation to be terminated by canonical release factors. Importantly, the 
coding sequence of tmRNA encodes a peptide degradation tag, which marks the released 
nascent peptide for degradation by the ClpXP protease (reviewed in (Janssen and Hayes, 
2012)). 
The main components that perform trans-translation are the RNA molecule tmRNA and the 
small protein SmpB, along with elongation factors EF-Tu, EF-G, and release factors RF1 or RF2 
(reviewed in (Himeno et al., 2014)). The 5’ and 3’ ends of tmRNA form the tRNA-like domain 
(Figure 2.17), which is similar to the acceptor stem of canonical tRNA. Alanyl-tRNA synthetase 
recognizes the G:U wobble base pair and charges it with alanine (Komine et al., 1994). Outside 
of the tRNA-like domain, E. coli tmRNA contains 4 pseudoknots, the function of which is 
unknown (Nameki et al., 2000) (Figure 2.17). However in between pseudoknots 1 and 2 is a 
small reading frame that encodes the peptide sequence AANDENYALAA followed by the stop 
codon UAA (Keiler et al., 1996). 
 
Figure 2.17. The secondary structure (left) and atomic model (right) of tmRNA. PK1 to PK4 
indicate the location of the four pseudoknots. The ssrA tag is indicated in green, and the GU 




In the first step of trans-translation, the small protein SmpB binds to the tRNA-like domain of 
tmRNA, taking the place where the anticodon loop of a tRNA would be (Figure 2.17), 
suggesting that the tRNA-like domain and SmpB together mimic tRNA (Bessho et al., 2007; 
Kurita et al., 2007). SmpB has a globular core and a C-terminal tail rich in positive amino acids, 
which renders it unstructured in solution (Dong et al., 2002; Someya et al., 2003). Studies have 
shown that binding of SmpB protects tmRNA from degradation, and plays an important role 
in facilitating the aminoacylation with Ala (Barends et al., 2001; Hanawa-Suetsugu et al., 2002; 
Shimizu and Ueda, 2002). Following aminoacylation, tmRNA-SmpB forms a quaternary 
complex with EF-Tu and GTP and binds to the ribosomal A site. A crystal structure of tmRNA-
SmpB on the Thermus thermophilus ribosome revealed that Y126 of SmpB stacks with the 
decoding center nucleotide G530, and the decoding bases A1492 and A1493 are ”flipped out” 
(Figure 2.18) (Neubauer et al., 2012). While the conformation of these bases differ from 
canonical decoding during translation elongation (see section 2.1.3), they still induce a closed 
conformation of the 30S subunit, which triggers GTP hydrolysis by EF-Tu, allowing the 
aminoacylated tmRNA to accommodate into the A site (Neubauer et al., 2012). 
 
Figure 2.18. Conformation of the T. Thermophilus ribosome decoding center in the presence 




A recent, high-resolution cryo-EM structure of the E. coli tmRNA-SmpB in several states during 
trans-translation showed that during accommodation, the globular domain of SmpB rotates 
into the A site, and the acceptor arm of the tRNA-like domain moves into the peptidyl-
transferase center (Rae et al., 2019). This motion mimics the distortion of tRNA during the 
accommodation step of canonical elongation (Reviewed in (Rodnina et al., 2005)).  
With tmRNA-SmpB occupying the ribosomal A site, peptide bond formation transfers the 
nascent chain from the P-site tRNA to tmRNA. In the following steps, tmRNA must be 
translocated into the P site, and the first codon of the tag sequence must be presented in the 
A site. This process is facilitated by EF-G (Ramrath et al., 2012); it has been shown that EF-G 
promotes the release of deacylated tRNA and the truncated mRNA from the ribosome 
(Ivanova et al., 2005).  
Notably, the mRNA features such as a Shine-Dalgarno sequence that establish a reading frame 
for the ribosome are not present on the mRNA-like domain of tmRNA. Only recently did high 
resolution cryo-EM structures reveal that the final couple of residues of the SmpB C-terminal 
tail interacts with the first few nucleotides of the mRNA-like domain (Rae et al., 2019). 
Previous studies had shown that the nucleotides preceding the first codon of the tag sequence 
are essential for positioning the first codon (Konno et al., 2007; Lee et al., 2001); together, 
these findings suggest that the SmpB C-terminal tail is important for maintenance of the 
tmRNA reading frame. 
Through each cycle of elongation, tmRNA-SmpB moves stepwise from the A site through the 
P site, and finally past the E site (Figure 2.19) (Rae et al., 2019). The switch from the truncated 
mRNA to the coding sequence on tmRNA is mediated by the flipping of the SmpB C-terminal 
tail. During accommodation, the C-terminal tail is folded into an α-helix in the mRNA entry 
channel in the A site (Figure 2.19 steps 2 and 3) (Rae et al., 2019; Ramrath et al., 2012). 
Following accommodation, the α-helix flips into the mRNA entry channel in the E site, with 
glycine 132 acting as a hinge during this dramatic structural rearrangement (Figure 2.19 step 
5) (Rae et al., 2019). This frees up the mRNA entry channel in the A site, allowing the mRNA-
like domain of tmRNA to bind. Trans-translation requires truncated mRNA to function (Ivanova 
et al., 2004; Kurita et al., 2014), which can be explained by the central role of the C-terminal 
tail in binding to the A site and E site parts of the mRNA path. When mRNA is present in the 




SmpB to discriminate between non-stop stalled ribosomes and ribosomes on intact mRNA 
(Miller and Buskirk, 2014). 
As translation of the tmRNA coding sequence progresses, the head of SmpB is displaced not 
into the E site, but towards the solvent side of the ribosome, so that it does not clash with the 
deacylated E site tRNA (Figure 2.19 steps 8 and 9)(Rae et al., 2019). Throughout this process, 
pseudoknot 2 of tmRNA maintains contact with ribosomal protein S3, which coordinates the 
position of tmRNA (Rae et al., 2019).  
 
Figure 2.19. Mechanism of tmRNA-SmpB-mediated trans-translation according to recently 
published cryo-EM structures (Rae et al., 2019). 
The coding sequence of tmRNA ends with the stop codon UAA, which can be recognized by 
both RF1 and RF2 (see section 2.1.4). Termination occurs just as during regular translation, 




product tagged with the ssrA sequence AANDENYALAA (Keiler et al., 1996), is targeted by 
cellular proteases for degradation. In E. coli, these include proteases FtsH and Lon, which 
consume ATP in order to unfold proteins and translocate them into the protease lumen (Choy 
et al., 2007; Herman et al., 1998). Within one mechanism, tmRNA-SmpB rescues non-stop 
stalled ribosomes, and also ensures the degradation of the unfinished translation product. 
Trans-translation seems to be the most universally utilized ribosome rescue system in bacteria; 
tmRNA and SmpB gene sequences have been annotated in almost all sequenced bacterial 
genomes. While the consistent level of non-stop ribosome stalling points to tmRNA-SmpB 
being a translational quality control system under all conditions (Ito et al., 2011; Moore and 
Sauer, 2005), in certain bacterial species it also plays specific physiological roles. In Bacillus 
subtilis and Strepomyces coelicolor, for example, tmRNA-SmpB regulates sporulation (Abe et 
al., 2008; Barends et al., 2010). In Salmonella typhimurium and Yersinia pestis, which causes 
typhoid fever and plague, respectively, deletion of tmRNA-SmpB leads to reduction of 
virulence (Julio et al., 2000; Okan et al., 2010), suggesting a role for trans-translation in 
bacterial pathogenesis. 
Interestingly, recent studies have also implicated trans-translation in the monitoring of co-
translational protein folding. While investigating ssrA-tagged substrates, Hayes and colleagues 
found that overexpressed large multidomain proteins are tagged in various sites (Hayes and 
Keiler, 2010). This tagging activity was not correlated with RNase activity or rare codons, but 
is increased upon heat shock and deletion of the ribosome-associated DnaK chaperone 
(Calloni et al., 2012; Hayes and Keiler, 2010). One possible explanation is that heat shock and 
loss of DnaK increases the probability of misfolding of the nascent peptide during translation, 
however because DnaK is involved in many processes in the cell, this connection is somewhat 
tenuous. Rather, it serves to highlight the need to further investigate ssrA-tagged peptides, in 
order to understand the wider physiological roles of trans-translation. 
2.3.2 ArfA 
The importance of ribosome rescue has been known for over two decades, but until relatively 
recently it was unclear why deletion of tmRNA-SmpB is not lethal in many bacteria, for 
example in E. coli (Komine et al., 1994). Chadani and colleagues performed mutagenesis on 
ΔssrA strains and identified mutants that required tmRNA-SmpB for growth (Chadani et al., 




mutants with plasmids carrying the gene ydhL rescued the growth defect (Chadani et al., 2010). 
ydhL was renamed arfA, for alternative ribosome rescue factor. 
ArfA is a small protein of approximately 70 amino acids, with only the first 47 essential for its 
function (Garza-Sanchez et al., 2011). Notably, ArfA alone did not exhibit peptidyl-tRNA 
hydrolysis activity on stalled ribosomes in vitro, but could rescue stalled ribosomes when 
supplemented with E. coli S30 extract, indicating that additional factors are required for ArfA-
mediated ribosome rescue (Chadani et al., 2011b). Subsequent studies using the PURE system, 
which is an in vitro coupled transcription and translation reaction mix, identified RF2 as the 
necessary and sufficient component that facilitates ArfA-mediated rescue (Chadani et al., 
2012; Shimizu, 2012). Since RF2 is the component carrying the GGQ-motif that hydrolyzes 
peptidyl-tRNA, it was hypothesized that ArfA recapitulates the interaction between RF2 and 
stop codons, allowing RF2 to catalyze peptide release despite the absence of a stop codon 
(Chadani et al., 2012; Shimizu, 2012). 
Several recent structural studies have clarified how ArfA recruits RF2 and facilitates peptidyl-
tRNA hydrolysis (Demo et al., 2017; Huter et al., 2017b; James et al., 2016; Ma et al., 2017; 
Zeng et al., 2017). ArfA binds to the small subunit of the ribosome (Figure 2.20a). While its C-
terminal residues reach into the mRNA entry channel, the N-terminal and middle portion of 
the protein interacts extensively with secondary structure elements of domain 3 and domain 
2 of RF2.  It was suggested that the binding of the C-terminal residues in the mRNA entry 
channel causes ArfA to reject ribosomes stalled with mRNA extending past the P site (Kurita 
et al., 2014). Interestingly, no interaction between ArfA and the SPF motif of RF2 was observed. 
The SPF motif, as described in section 2.1.4, is responsible for stop codon recognition during 
canonical termination (Korostelev et al., 2008; Korostelev et al., 2010; Laurberg et al., 2008). 
This finding made it apparent that ArfA does not recruit RF2 by mimicking stop codons. Rather, 
the interactions between ArfA and RF2 serve to directly stabilize a specific conformation of 
the RF2 switch loop (Demo et al., 2017; Huter et al., 2017b; James et al., 2016; Ma et al., 2017; 
Zeng et al., 2017). This conformation of the switch loop stabilizes RF2 in its open conformation 
(Figure 2.20b). Similar to canonical termination, the open conformation of RF2 places the GGQ 
motif in the optimal position in the peptidyl-transferase center for peptidyl-tRNA hydrolysis 





Figure 2.20. Cryo-EM structure of ArfA on the 70S E. coli ribosome. (a) ArfA and RF2 bound to 
the ribosome. (b) Close up view of the interaction between the P-site tRNA (green), ArfA (pink), 
and accommodated RF2 (purple) (Adapted from (James et al., 2016)). 
During canonical termination, the switch loop of release factors interacts with the decoding 
center residues A1492, A1493, G530, and A1913, which contributes to the stabilization of the 
open conformation of the release factors (Korostelev et al., 2008; Laurberg et al., 2008). 
However, these interactions do not occur between RF2 and the ribosome with ArfA present. 
Instead, Glu 30 of ArfA stacks with G530 (Figure 2.21a), maintaining G530 in the same anti 
conformation as is observed during stop codon recognition (Figure 2.21b). Meanwhile, A1493 
is flipped out, and A1492 stacks with A1913 of the 16S rRNA (Demo et al., 2017; Huter et al., 
2017b; James et al., 2016; Ma et al., 2017; Zeng et al., 2017). This conformation is reminiscent 
of what was observed in tmRNA-SmpB bound ribosomes (Neubauer et al., 2012).  
 
Figure 2.21. Conformation of decoding center residues during (a) ArfA-mediated ribosome 
rescue and (b) canonical termination (James et al., 2016). 
Beyond certain structural similarities, there is a strong physiological connection between ArfA 




RNaseIII, resulting in a non-stop mRNA (Garza-Sanchez et al., 2011; Schaub et al., 2012). When 
tmRNA-SmpB is present, non-stop stalling on the truncated arfA transcript is resolved via 
trans-translation (discussed in section 2.3.1), leading to ssrA-tagging and degradation of ArfA. 
In the absence of tmRNA, the truncated form of ArfA is expressed (Chadani et al., 2011a; 
Garza-Sanchez et al., 2011; Schaub et al., 2012). In this scenario, it is unclear which mechanism 
releases ArfA from the non-stop stalled ribosomes. The regulation of ArfA by tmRNA-SmpB 
strongly suggests that ArfA acts as a back-up rescue mechanism to trans-translation; only 
when the tmRNA-SmpB is overwhelmed does ArfA come into play. 
While tmRNA-SmpB is found in most sequenced bacterial genomes, ArfA has only been 
identified in some species of β- and γ-proteobacteria (Schaub et al., 2012). It is possible that 
in other species, mechanisms similar to that of ArfA exist; one ArfA-like factor was recently 
discovered in Francisella tularensis. The factor in question was named ArfT, and it rescues non-
stop stalled ribosomes by recruiting RF1 (Goralski et al., 2018). Like ArfA, ArfT has positively 
charged residues on its C-terminal end that may mediate binding to the mRNA entry channel. 
Further studies are required to elucidate how it interacts with the ribosome and with RF1, and 
structural comparisons between ArfA and ArfT could shed light on why these factors only 
recruit one release factor and not the other. 
2.3.3 ArfB 
ArfB, the third non-stop rescue factor, was first identified as a putative peptidyl-tRNA 
hydrolase because its sequence bore strong similarities to domain 3 of release factors, and 
because it contains the GGQ motif that in release factors catalyzes peptidyl-tRNA hydrolysis 
(Handa et al., 2011; Korostelev et al., 2008; Laurberg et al., 2008). When added to non-stop 
stalled ribosomes assembled using the PUREsystem, ArfB exhibited peptidyl-tRNA hydrolysis 
activity (Handa et al., 2011). 
In a subsequent study, ArfB was found to be a multicopy suppressor of synthetic lethality in a 
ΔssrA ΔarfA E. coli strain. When supplied with multiple copies of plasmids carrying various E. 
coli genes, a plasmid carrying the yaeJ, the gene that encodes ArfB, was found to restore cell 
growth in this strain (Chadani et al., 2011b). While it should be noted that endogenous levels 
of ArfB expression was not sufficient to rescue the synthetic lethality phenotype, this 




ArfB consists of 140 amino acids. Mutagenesis studies revealed that it is indeed the GGQ motif 
in the N-terminal domain that mediates peptidyl-tRNA hydrolysis (Chadani et al., 2011b; 
Handa et al., 2011). It was also shown that the last 40 C-terminal residues are essential for the 
ribosome rescue activity of ArfB (Chadani et al., 2011b). Furthermore, based on sucrose 
gradient centrifugation assays, whereby polysomes, 70S ribosomes, and ribosomal subunits 
were separated based on their sedimentation rate, it was postulated that ArfB is a 70S 
ribosome-bound factor (Chadani et al., 2011b; Handa et al., 2011). 
The redundancy of ArfB in E. coli, as well as the apparent lack of a direct regulatory relationship 
with tmRNA-SmpB and ArfA (discussed in section 2.3.2), led to speculation on the function of 
ArfB. In the early biochemical characterization studies of ArfB, it was shown that ArfB 
catalyzed peptidyl-tRNA hydrolysis when incubated with ribosomes stalled on rare codon 
clusters in the PUREsystem, which have mRNA extending past the P site (Handa et al., 2011; 
Shimizu, 2012). Since both tmRNA-SmpB and ArfA show marked decrease in rescue activity on 
ribosomes stalled with mRNA within the mRNA entry channel (Ivanova et al., 2004; Kurita et 
al., 2014), these results led to the hypothesis that ArfB is less sensitive to mRNA length and 
serves to also rescue ribosomes stalled in the middle of mRNA (Handa et al., 2011; Shimizu, 
2012).  
In a crystal structure of ArfB bound to the Thermus thermophilus ribosome, it was shown that 
ArfB has a globular N-terminal domain, a long flexible linker that spans approximately 40 Å on 
the ribosome, and a C-terminal tail that forms an α-helix (Figure 2.22a) (Gagnon et al., 2012). 
Crucially, the C-terminal tail is unstructured in an NMR structure (Kogure et al., 2014), but in 
its bound form is folded within the mRNA entry channel (Figure 2.22b). It is worth noting that 
C-terminal tails rich in positively charged residues that bind in the mRNA entry channel is a 
common feature among the tmRNA-SmpB, ArfA, and ArfB rescue systems. Gagnon and 
colleagues observed that binding of the C-terminal tail would clash sterically with mRNA 
extending past the P site, casting into doubt how ArfB might mediate rescue of ribosomes 
stalled on rare codon clusters. Based on this structure, it was proposed that the C-terminal tail 
of ArfB probes the mRNA entry channel, and if the channel is empty, it moves the N-terminal 
domain through the flexible linker, thereby positioning the GGQ motif next to the CAA end of 





Figure 2.22. Crystal structure of (a) ArfB bound to the (b) Thermus thermophilus ribosome 
(adapted from (Gagnon et al., 2012)). 
The crystal structure also provided insights into the decoding center of the ribosome during 
ArfB-mediated ribosome rescue. In this model, G530 stacks with Arg 118 of ArfB (Figure 2.23a), 
while A1492 is partially flipped out (Figure 2.23b) (Gagnon et al., 2012). Pro 110 of ArfB stacks 
with A1493 and A1913, which may serve as an anchor for the flexible linker. The conformation 
of these decoding center residues avoids steric clashes with the ArfB C-terminal tail (Figure 
2.23b) (Gagnon et al., 2012). Intriguingly, the final 10 residues of ArfB were not resolved in 
this structure, even though they were shown to be essential for ribosome binding (Handa et 
al., 2011). 
 
Figure 2.23. Configuration of the decoding center residues (a) G530, (b) A1493 and A1492 
with ArfB bound to the ribosome (in orange). ArfB is labeled as YaeJ in the graph, and the blue 
nucleotides indicate the orientations of A1493 and A1492 when a tRNA occupies the 




While not as widely found in bacteria as tmRNA-SmpB, ArfB is conserved in more species than 
ArfA, with 34% of sequenced bacterial species containing ArfB homologs. Despite the strong 
evolutionary conservation, ArfB does not appear to be essential in bacteria (Feaga et al., 2014). 
In eukaryotes, on the other hand, ArfB homologs exist in all species from yeast to humans 
(Duarte et al., 2012). These homologs are targeted to mitochondria, which according to the 
endosymbiotic theory, could indicate that ArfB was present in alphaproteobacteria that were 
engulfed to form mitochondria (reviewed in (Martin et al., 2015)). 
The best-studied ArfB homolog is ICT1, which is a nuclear-encoded protein present in human 
mitochondria (Richter et al., 2010). Solution structures of ICT1 show striking similarities to 
ArfB (Figure 2.24). In addition to a very similar catalytic domain (Handa et al., 2010), ICT1 also 
has a C-terminal tail rich in positive residues; many of the residues in this region that are highly 
conserved in ArfB are also conserved in ICT1 (Akabane et al., 2014; Kogure et al., 2014). 
Homology modeling using the crystal structure of ArfB and the cryo-EM structure of ICT1 also 
suggested that the C-terminal tail of ICT1 folds into an α-helix bound in the mRNA entry 
channel (Lind et al., 2013). Based on these structural comparisons and sequence analyses, it 
is tempting to assume that these ICT1 residues interact with the mitoribosome in a similar way 
to how the ArfB C-terminal tail interacts with the bacterial ribosome. 
 
Figure 2.24. Comparison of the ArfB crystal structure and the ICT1 solution structure (adapted 
from (Akabane et al., 2014)). 
ICT1 is essential for cell viability (Richter et al., 2010), though its exact function in human 
mitochondria is still unclear. Studies in which ICT1 was added to bacterial translation systems 
show that similarly to ArfB, it can catalyze peptidyl-tRNA hydrolysis on ribosomes stalled on 




human cells (Feaga et al., 2016). However, cryo-EM structures of the human mitochondrial 
ribosome cast doubt on the functional role of ICT1. The structures showed that ICT1 is 
incorporated into the mitoribosomal large subunit, and it is named mL62 (formerly MRPL58) 
(Amunts et al., 2015; Brown et al., 2014). The position of mL62 on the large subunit is more 
than 80 Å away from the A site, where release factors typically bind (Brown et al., 2014). It 
was subsequently suggested that while ICT1 plays a structural role as a large ribosomal subunit 
protein, a fraction of ICT1 in mitochondrial remains unbound and can function as a stop codon-
independent release factor (Akabane et al., 2014), though there is as yet no definitive 
evidence of this unbound fraction of ICT1. More compelling is the finding that mutating the 
GGQ motif of ICT1 is detrimental to cell viability, which indicates that the hydrolytic activity of 
ICT1 is important for the cell (Richter et al., 2010). 
Of the ribosome rescue mechanisms that target non-stop stalling that have been discussed so 
far, only homologs of ArfB have been found in mitochondria (Duarte et al., 2012). It is possible 
that while ArfB is not essential in certain bacterial species such as E. coli, which have tmRNA-
SmpB as well as ArfA, its homologs have a much more significant role in mitochondrial 
translation. 
2.3.4 Coupled folding and binding mechanisms 
A common feature of tmRNA-SmpB, ArfA, and ArfB is the presence of positively charged amino 
acid sequences at the C terminus that bind within the mRNA entry channel of non-stop stalled 
ribosomes (Demo et al., 2017; Gagnon et al., 2012; Huter et al., 2017b; James et al., 2016; Ma 
et al., 2017; Neubauer et al., 2012; Rae et al., 2019; Zeng et al., 2017). Furthermore, NMR 
studies of SmpB and ArfB have shown that their positively charged C-terminal tails are 
unstructured in solution (Dong et al., 2002; Someya et al., 2003). It has been suggested for all 
three mechanisms that the unstructured regions facilitate recognition of the empty mRNA-
entry channel, thereby selecting stalled ribosomes for rescue (Gagnon et al., 2012; Kurita et 
al., 2014; Miller and Buskirk, 2014). 
Intrinsic disorder is a feature of many proteins involved in regulation of gene expression and 
signaling pathways (reviewed in (Dyson and Wright, 2005)). Intrinsically disordered domains 
do not have stable three-dimensional structures, and are defined by repetitive sequences of 
charged amino acids and the lack of bulky hydrophobic residues (Romero et al., 2001). While 




disorder persists under cellular solvent conditions (Theillet et al., 2016). The behavior of these 
dynamic and flexible regions differ greatly from that of folded protein domains, and have 
important implications on binding interactions in the cell. It has long been postulated that the 
advantage of intrinsic disorder is fast association, high specificity, and low affinity, all of which 
enable regulatory networks to activate and deactivate signaling cascades very quickly, in 
particular when cellular concentrations of these regulatory proteins are low (reviewed in 
(Dyson and Wright, 2005; Mollica et al., 2016)). 
In their bound state, intrinsically disordered proteins (IDPs) often assume a secondary 
structure; the association of an IDP and its binding partner is therefore a “coupled binding and 
folding reaction”, with the enthalpy of binding compensating for the entropic cost of folding 
(reviewed in (Dyson and Wright, 2002)). IDPs typically have many charged residues, and 
electrostatics have been shown to play a role in increasing kON through electrostatic steering 
(Ganguly et al., 2012). However, electrostatic steering alone does not appear to account for 
diffusion controlled association rates, where binding so fast that it is limited by the rate of 
diffusion (Shammas et al., 2013). It has been proposed that intrinsic disorder itself accelerates 
association through a “fly-casting” mechanism (Shoemaker et al., 2000). Fly-casting refers to 
the extended, flexible configurations of IDPs in solution, which allows them to first form weak 
interactions with their binding partners over long distances, thereby increasing the “capture 
radius” of an IDP. These interactions lower the free energy of folding, allowing specific short-
range interactions to form, so that the binding partner effectively “reels in” the IDP 
(Shoemaker et al., 2000). 
Experimental evidence of the fly-casting hypothesis is scarce, mostly due to technical 
constraints.  In fact, in some studies, stabilizing transient secondary structures of the IDP in 
solution was found to increase the rate of binding (kON) for some proteins (Arai et al., 2015; 
Iesmantavicius et al., 2014). This led to another outstanding question regarding the coupled 
binding and folding of IDPs: whether the association goes through a conformational selection 
or an induced fit mechanism. In the former, IDPs where transient secondary structures have 
formed are preferentially bound, which drives the equilibrium towards IDPs with pre-formed 
structures. In the latter, folding occurs on the binding partner following binding of the fully 




While these theories on the role of intrinsic disorder in protein binding have been in place for 
many years, experimental validation is still a developing field. The commonly used methods 
to study IDP binding include NMR spectroscopy and rapid kinetics techniques, and kinetic 
models have been proposed that can potentially differentiate between the conformational 
selection and induced fit mechanisms (Shammas et al., 2016). However, recent studies show 
that IDP binding mechanisms are diverse and resist simple categorization. For example, 
measured kON values range from 107 M-1s-1 for the KIX domain of CREB-binding protein (CBP) 
and its ligands (Shammas et al., 2013), to 630 M-1s-1 for spectrin tetramerization (Shammas et 
al., 2012). Kd values have also been measured from nanomolar range to micromolar range, 
refuting the assumption that all IDPs form low affinity complexes with their binding partners 
(Shammas et al., 2016). Additionally, experimental data suggests that IDP binding mechanisms 
can combine aspects of both conformational selection and induced fit, in which pre-formed 
structures play a role in initial binding, but folding of the IDP is only completed after binding 
(Mollica et al., 2016).  
The role of intrinsic disorder in protein-protein interactions appear to vary between different 
IDPs, and careful consideration of structural information as well as kinetic data is necessary to 
understand specific binding interactions. In the case of ArfB and ICT1, the positively-charged 
C-terminal tail could facilitate electrostatically-enhanced binding to the ribosome via 
interactions with the negatively charged rRNA backbone (Handa et al., 2010; Kogure et al., 
2014). Rapid association could compensate for low expression levels of ArfB in E. coli 
(Taniguchi et al., 2010). Current theories on the binding of intrinsically disordered proteins 
provide a framework for understanding ArfB-ribosome interactions, and a detailed 
investigation into the kinetics of ArfB-mediated rescue could give additional insight into these 





2.4 Ribosome rescue in mitochondria 
ArfB is set apart from the other known bacterial ribosome rescue systems by its ability to 
catalyze peptidyl-tRNA hydrolysis without external factors (Chadani et al., 2011b; Handa et al., 
2011), and by its evolutionary conservation in the mitochondria of all eukaryotes while 
tmRNA-SmpB and ArfA are entirely absent (Duarte et al., 2012). While eukaryotic translation 
has many significant differences from prokaryotic translation (reviewed in (Dever et al., 2018; 
Hellen, 2018; Merrick and Pavitt, 2018)), mitochondrial translation bears some structural and 
biochemical similarities to bacterial translation (reviewed in (Greber and Ban, 2016; Ott et al., 
2016)), to the extent that certain bacterial and mitochondrial factors are interchangeable 
(Feaga et al., 2016). These similarities allow us to infer the function of bacterial translation 
factor homologs in human mitochondria, in particular the ArfB homolog ICT1. 
2.4.1 Comparison of mitochondrial and bacterial ribosomes 
The mammalian 55S mitoribosome is composed of a 28S small subunit with a 12S rRNA and 
30 proteins, and a 39S large subunit with a 16S rRNA, 52 proteins, and the CP-tRNA (Figure 
2.25a) (Greber and Ban, 2016). The CP-tRNA is a tRNA molecule (tRNAPhe in porcine 
mitoribosome structures and tRNAVal in human mitoribosome structures) that takes the place 
of bacterial 5S ribosomes in the central protuberance (Brown et al., 2014; Greber et al., 2014). 
Mitochondrial rRNAs are significantly shortened compared to bacterial rRNAs. Indeed, recent 
cryo-EM structures of mammalian mitoribosomes show that while the surface of the bacterial 
ribosome (Figure 2.25b) mostly consists of rRNA, the surface of the mitochondrial ribosome 
is covered in proteins (Figure 2.25c). (Amunts et al., 2015; Brown et al., 2014; Greber et al., 
2015; Greber et al., 2014). The increased protein content in mammalian mitochondrial 
ribosomes compensates for the structural roles played by bacterial rRNA, and confer 
mitochondrial-specific functions to the mitoribosome such as membrane attachment and 
mRNA recruitment (Amunts et al., 2015; Greber et al., 2015; Greber et al., 2014). The 13 
components of the oxidative phosphorylation pathway synthesized by the mitochondrial 
ribosome are all targeted to the mitochondrial membrane, therefore many of the additional 






Figure 2.25. Structures of the (a) human mitochondrial 55S ribosome and the (b) bacterial 70S 
ribosome. (c) The exterior of the mitochondrial ribosome is covered with protein (yellow and 
blue), while the bacterial ribosome exterior is covered with rRNA (red and green) (adapted 
from (Greber and Ban, 2016)). 
Extensive differences in composition from the bacterial ribosome notwithstanding, the 
functional core of the mitochondrial ribosome is highly conserved. The peptidyl-transferase 
center is conserved, and structures that capture a nascent peptide in the peptide exit tunnel 
of the mammalian mitoribosome show that it is very similar to that of the bacterial ribosome; 
the residues lining the mitochondrial tunnel are however more hydrophobic, likely an 
adaptation that allows the mitoribosome to specialize in synthetizing membrane proteins 
(Brown et al., 2014; Greber et al., 2014). The reduction in mitoribosomal rRNA length 
eliminated a number of residues that contact A site and P site tRNAs in bacteria, however the 
key interactions with the CCA acceptor end and the anticodon stem loop of tRNAs are 
conserved (Amunts et al., 2015; Greber et al., 2015). 
In the decoding center, the nucleotides A918, A919, and G256 correspond to A1492, A1493, 
and G530 of the bacterial decoding center (Figure 2.26a) (Greber et al., 2015). Relevant to the 
binding of ArfB-like proteins, the mRNA entry channel is well conserved in the A and P sites 
(Figure 2.26b), while the channel opening is remodeled. The opening of the mRNA entry 
channel lacks proteins that have helicase activity (S3 and S4 in bacteria), but includes mS39, 
which could facilitate the recruitment of leaderless mRNAs through the RNA-binding PPR 





Figure 2.26. The conserved functional core of the mammalian mitochondrial ribosome. (a) The 
decoding center. (b) The mRNA path (adapted from (Greber and Ban, 2016)). 
2.4.2 mRNA processing in mitochondria 
Since the rescue of ribosomes stalled on truncated mRNAs is a proposed function of ICT1 
(Feaga et al., 2016), the structure and processing of mitochondrial mRNAs are of interest. The 
human mitochondrial genome encodes 13 proteins that make up the core components of 
oxidative phosphorylation pathway, and mRNA, rRNA as well as a subset of mitochondrial 
tRNAs are transcribed in mitochondria (reviewed in (Ott et al., 2016)). Mitochondrial primary 
transcripts are polycistronic, with protein coding sequences interspersed with mitochondrial 
tRNAs and rRNAs (Anderson et al., 1981). The primary transcripts are cleaved to release tRNAs, 
rRNA, and mRNA for further maturation (reviewed in (D'Souza and Minczuk, 2018)). 
Primary transcripts are cleaved by RNase P from the 5’ end, and RNase Z from the 3’ end 
(Brzezniak et al., 2011; Holzmann et al., 2008). Mitochondrial mRNAs are subsequently 
polyadenylated, with the sole exception of MT-ND6. In contrast to eukaryotic mRNAs, which 
are stabilized by polyadenylation, this modification stabilizes some mitochondrial mRNAs and 
destabilizes others, and is subject to regulation by enzymes such as PDE12 (Nagaike et al., 
2005; Rorbach et al., 2011). Furthermore, polyadenylation completes the stop codon of 7 
mitochondrial open reading frames (Temperley et al., 2010b). 
Cleavage of the primary transcripts, polyadenylation, and removal of the poly(A) sequences 
create possibilities for the generation of non-stop mRNAs in mitochondria. While it is unclear 




proteins such as ICT1 and C12orf65 suggest that ribosome rescue may play an important role 
in mitochondrial translation (Burroughs and Aravind, 2019; Duarte et al., 2012). 
2.4.3 Mitochondrial translation termination 
As in bacterial translation, mitochondrial translation termination involves release factor-
catalyzed peptidyl-tRNA hydrolysis (Ott et al., 2016). ICT1, C12orf65, mtRF1, and mtRF1a were 
identified as putative release factors based on sequence homology to bacterial release factors, 
and all four proteins contain the GGQ motif (Duarte et al., 2012; Handa et al., 2010; Kogure et 
al., 2012). Unlike ICT1 and C12orf65, mtRF1 and mtRF1a have codon recognition domains 
reminiscent of the PxT domain of bacterial RF1, although only mtRF1a has shown peptidyl-
tRNA hydrolysis activity in vitro (Korostelev et al., 2010; Lind et al., 2013; Soleimanpour-Lichaei 
et al., 2007).  
In mitochondria, the codon UGA codes for tryptophan, with UAA and UAG utilized as stop 
codons for most open reading frames (Temperley et al., 2010b). Homology modeling showed 
that mtRF1a can decode these stop codons similarly to RF1, while it is still unclear why mtRF1 
is inactive in in vitro assays (Lind et al., 2013). However for the genes MT-CO1 and MT-ND6, 
the coding sequence ends with AGA and AGG, respectively. It is still unclear how translation 
termination occurs on these two genes; one hypothesis states that because mitochondria lack 
the tRNAArg encoded by these two codons, ribosome stalling induces a -1 frameshift which 
creates an in-frame UAG stop codon (Temperley et al., 2010a). On the other hand, ICT1 and 
C12orf65 have also been proposed to terminate translation on AGA and AGG codons, due to 
their lack of a codon recognition domain (Lind et al., 2013). To understand the role of ArfB-
like factors in ribosome rescue and canonical termination in mitochondria, a more detailed 




2.5 Scope and aim of thesis 
In this study, we set out to construct a kinetic model of ArfB-mediated ribosome rescue, with 
the specific aims of establishing substrate specificity and understanding the interplay of the 
N-terminal and C-terminal domains of ArfB. While previous studies showed the hydrolytic 
activity of ArfB on non-stop stalled ribosomes and on ribosomes stalled on rare codon clusters, 
the experiments were carried out under equilibrium conditions and gave limited mechanistic 
insight. Furthermore, the crystal structure of ArfB bound to the ribosome showed that binding 
of the ArfB C-terminal tail in the mRNA entry channel should clash sterically with mRNA 
extending past the P site. This raised question regarding the role of the C-terminal tail: if the 
C-terminal tail is essential for ArfB activity, how can ArfB catalyze peptidyl-tRNA hydrolysis on 
ribosomes stalled in the middle of mRNAs?  
To address the issue of substrate specificity, we used a fully reconstituted E. coli translation 
system and purified ArfB to conduct both steady-state and pre-steady state experiments. By 
supplying aminacyl-tRNAs that only encode the first two codons of our model mRNA, we could 
purify stalled ribosomes that had a quantifiable radioactive dipeptidyl-tRNA in the P site, an 
empty A site, and variable lengths of mRNA extending into the mRNA entry channel. These 
model ribosomal complexes allowed us to directly measure the rate of ArfB-mediated 
peptidyl-tRNA hydrolysis on different potential substrate complexes using the quenched-flow 
technique. We could also perform classical Michaelis-Menten titrations to obtain specificity 
constants for different stalled ribosomes. 
In addition to the catalytic activity of ArfB, the association and dissociation of ArfB from stalled 
ribosomes are also of interest. tmRNA-SmpB, ArfA, and ArfB all have unstructured C-terminal 
domains, and for all three systems it has been suggested that they probe the mRNA entry 
channel for mRNA and ensure substrate specificity. However, this has yet to be conclusively 
shown due to the lack of kinetic data on the binding of rescue factors. While the crystal 
structure shows the ArfB C-terminal tail as an α-helix in the mRNA entry channel, the atomic 
model could not explain the importance of several C-terminal residues according to 
mutational experiments, and it is not known what role the folding of the C-terminal domain 
plays in ArfB activity. 
By incorporating fluorescence labels into our model ribosomal complexes as well as into 




resonance energy transfer (FRET) and the stopped flow technique. Fluorimetric titrations 
provided further thermodynamic parameters of binding; both FRET and anisotropy were used 
to confirm the results. Experiments were carried out at 37°C and at 20°C with the goal of 
eventually modeling ArfB behavior at one of these temperatures. The interpretation of kinetic 
data was aided by atomic models obtained by cryo-electron microscopy of ArfB-bound 
ribosome complexes. Cryo-EM experiments and analysis were performed by Claudia Müller 
and Daniel Wilson (Institute for Biochemistry and Molecular Biology, University of Hamburg), 
and by Valentyn Petrychenko and Niels Fischer (Department of Structural Dynamics, Max 
Planck Institute for Biophysical Chemistry). 
Finally, the question remains of the physiological significance of ArfB. To study factors that 
potentially interact with ArfB in the cell, we used the pKOV vector to generate E. coli strains 
in which chromosomally encoded ArfB is tagged with a 3xFLAG tag. This enables us to pull 
down endogenously expressed ArfB using immunoprecipitation, and submit the protein and 
potential interacting proteins for analysis by mass spectrometry.  
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3 MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Chemicals 
Table 3.1. List of chemicals 
Chemical Manufacturer 
[3H]-N-formylmethionine Perkin Elmer 
[14C]-phenylalanine Perkin Elmer 
Acrylamide, 40% w/v solution, 29:1 SERVA Electrophoresis 
Agarose SERVA Electrophoresis 
Ammonium chloride Merck Millipore 
Ammonium persulfate (APS) Merck Millipore 
ATTO 540-Q maleimide ATTO-TEC 
β-mercaptoethanol Sigma-Aldrich 
Boric acid Carl Roth 
Bromophenol Blue sodium salt Merck Millipore 
Chloramphenicol Sigma-Aldrich 
cOmplete protease inhibitor cocktail tablets Roche 
DMSO Merck Millipore 
DNaseI Jena Bioscience 
DNA Stain G SERVA Electrophoresis 
dNTP mix New England Biolabs 
Dpn1 New England Biolabs 
DTT AppliChem 
EDTA Sigma-Aldrich 
Ethanol (EtOH) Merck Millipore 
Fluorescein-5-maleimide Thermo Fischer 
Glycerol Merck Millipore 
GTP Sigma-Aldrich 
HEPES Sigma-Aldrich 
HF buffer, 5x New England Biolabs 
Imidazole Carl Roth 
IPTG Carl Roth 
IRGASAFE scintillation cocktail Perkin Elmer 
Kanamycin sulfate SERVA Electrophoresis 
Ni-IDA resin Macherey-Nagel 
Magnesium chloride hexahydrate Merck Millipore 
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Methylene blue Merck Millipore 
Perfect Protein Markers, 15-150kDa EMD Millipore 
Phosphoenolpyruvate Sigma-Aldrich 
Phusion polymerase New England Biolabs 
Potassium acetate Merck Millipore 
Potassium chloride Merck Millipore 
Potassium hydroxide Merck Millipore 
Pyruvate kinase from rabbit muscle Roche 
SmartLadder MW 1700-10 Eurogentec 
Sodium chloride Merck Millipore 
Sodium dodecylsulfate (SDS) SERVA Electrophoresis 
TEMED Sigma-Aldrich 
Trichloroacetic acid (TCA) Merck Millipore 
Tris-HCl Merck Millipore 
Tryptone Carl Roth 
Yeast extract Carl Roth 
 
  




Table 3.2. Buffer composition 
 Buffer name and pH Composition 
ArfB purification Lysis buffer (pH 7.5) Tris-HCl 20 mM 
NaCl 500 mM 
Glycerol 10% v/v 
β-mercaptoethanol 1 mM 
Buffer SA (pH 7.0) HEPES 40 mM 
KCl 300 mM 
MgCl2 7 mM 
β-mercaptoethanol 10 mM 
Buffer SB (pH 7.0) HEPES 40 mM 
KCl 1000 mM 
MgCl2 7 mM 
β-mercaptoethanol 10 mM 
mRNA purification Buffer FA (pH 6.0) BisTris 30  mM  
EDTA 1 mM 
NaCl 300mM 
Buffer FB (pH 6.0) BisTris 30 mM 
EDTA 1 mM 
NaCl 1.5 M 
Reaction buffers HAKM7 (pH 7.4) HEPES 50 mM 
NH4Cl 70 mM 
KCl 30 mM 
MgCl2 7 mM 
HAKM20 (pH 7.4) HEPES 50 mM 
NH4Cl 70 mM 
KCl 30 mM 
MgCl2 20 mM 
HKM7 (pH 7.4) HEPES 50 mM 
KCl 30 mM 




LB broth NaCl 1% w/v 
 Tryptone 1% w/v 
 Yeast extract 0.5% w/v 
SDS-PAGE sample buffer (pH 6.8) Tris-HCl 50 mM 
 SDS 2% 
 Glycerol 10% v/v 
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 Bromophenol blue 0.1% v/v 
Sonication buffer (pH 7.9) Tris-HCl 20 mM 
NaCl 150 mM 
EDTA 0.2 mM 
Glycerol 10% 
AFC buffer (pH 7.0) Tris-HCl 10 mM 
NaCl 150 mM 
 Triton X-100 0.1% 
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3.1.3 Primers and sequences 
Table 3.3. Primers for mutagenesis 











lepB A2F GGGCAAACATATTGAACATATTAGAATTCTCC 
 GGAGAATTCTAATATGTTCAATATGTTTGCCC 
Single mutated codons are shown in red. 





























The start codon AUG is indicated in blue. 
Table 3.5. List of vectors 
Vector Use Source 
pBSKII Standard cloning vector for model mRNAs Addgene 
pSUMO Protein expression vector for ArfB Addgene 





Figure 3.1. Map of the plasmid used to generate E. coli strains. The yaeQ operon carrying ArfB 
was cloned including its flanking 500 base pairs (grey), and a 3xFLAG tag (pink) was inserted 
into the C terminus of ArfB (red).  




3.2.1 ArfB overexpression and purification 
The arfB gene from E. coli strain K12 (UniProt ID: P40711) was cloned into a pSUMO vector 
with an N-terminal 6x His-tag followed by a cleavable SUMO tag. The vector contained an 
IPTG-inducible promoter and a kanamycin resistance cassette. The resulting plasmid was 
transformed into E. coli strain BL21 DE3 cells. Protein overexpression was induced with 250 
mM IPTG in 500 mL bacterial cultures at A600 0.6, after which the cultures were shaken for 6 
hours at 30°C. The cells were harvested by centrifugation (6000 xg for 20 min at 4°C) and the 
pellets were flash frozen in liquid nitrogen. The harvested cells were thawed in lysis buffer 
(Gagnon et al., 2012) supplemented with protease inhibitors (1 tablet of cOmplete EDTA-free 
Protease Inhibitor Cocktail per 10 g cells, Roche Diagnostics) and DNase1 (40 units per 10 g 
cells, Jena Bioscience), and lysed using the Emulsiflex C3 (Avestin). Cell lysates were clarified 
by centrifugation at 25,000 rpm for 1 h at 4°C (Avanti J-30I, rotor JA 30.50Ti, Beckman Coulter).  
6xHis-SUMO-tagged ArfB was enriched by incubating the clarified lysate with Ni-IDA resin (2 g 
per 10 g cells, Macherey Nagel) for 1 h at 4°C, and eluted with buffer SA supplemented with 
600 mM imidazole. Imidazole was removed from the solution by dialysis overnight into buffer 
SA at 4°C (D-Tube dialyzer, 3.5 kDa molecular weight cutoff, EMD Millipore), while 
simultaneously incubating the mixture with Ulp1 protease (4000 pmol per 10 g cells, purified 
in-house by Franziska Hummel) to cleave the 6xHis-SUMO tag. Untagged ArfB was purified by 
ion-exchange chromatography over a 5 mL HiTrap HP SP column (GE Healthcare).  Briefly, the 
column was charged with 100% buffer SB (1000 mM KCl) and equilibrated with buffer SA (300 
mM KCl). A gradient from 300 mM to 1000 mM KCl was then run over 12 column volumes 
(approximately 60 mL). 0.75 mL fractions were collected. The cleaved 6xHis-SUMO tag does 
not bind to the column, and untagged ArfB elutes at approximately 550 mM KCl. Fractions 
containing ArfB were identified by 15% SDS-PAGE, and ArfB concentration was determined 
using IF3 as a standard on SDS-PAGE gels. Protein band intensities were quantified using MiBio 
(Microtek). 
ArfB single-cysteine variants and slowly hydrolyzing ArfB (ArfBGAQ) were purified for 
fluorescence labeling. Wildtype ArfB does not contain cysteines, so positions 96 (lysine) or 112 
(arginine) were mutated to cysteine using the QuikChange mutagenesis protocol, while 
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position 27 (glycine) was mutated to generate ArfBGAQ. The resulting ArfB variants ArfB(K96C), 
ArfB(R112C), and ArfBGAQ were purified as described previously.  
The N-terminal domain of ArfB (ArfBNterm), truncated at position 101, was expressed using the 
same pSUMO vector described above. The overexpression and purification was performed as 
described above for full-length ArfB, with the exception of the tag cleavage and ion-exchange 
chromatography steps. The 6xHis-SUMO tag on ArfBNterm was first cleaved, then removed by 
incubation with Ni-IDA resin. ArfBNterm was further purified over a 5 mL HiTrap Q HP anion 
exchange chromatography column (GE Healthcare); ArfBNterm does not bind to the resin and 
was collected from the flow-through and concentrated. 
The C-terminal domain of ArfB (ArfBCterm) was truncated at position 106. The overexpression 
and purification was performed as described above for full-length ArfB. 
3.2.2 in vitro translation and purification of stalled ribosomes 
The non-stop mRNAs used in this project contain a ribosome binding site and a start codon 
followed by 1 to 34 additional codons. The sequences were derived from the E. coli lepB gene 
(UniProt ID: P00803), with the second codon mutated by site-directed mutagenesis to UUC 
(phenylalanine) for fluorescence labeling purposes. The modified DNA sequence was cloned 
into a pBSKII vector containing a T7 promoter. DNA templates for in vitro translation were 
generated by polymerase chain reactions (PCRs) with a T7 primer and a reverse primer that 
defined the length of the transcript. The PCR mixtures contained 0.02 u/μL Phusion 
polymerase (Thermo Fischer), 0.2 mM dNTP, 0.2 μM of each primer, 100 ng of the template 
plasmid, and 1x HF buffer. In vitro transcription was carried out in water for 3 h at 37˚C with 
10 ng DNA template, 1x transcription buffer, 10 mM DTT, 3 mM NTP mix, 5 mM GMP, 0.005 
u/μL pyrophosphatase (Lucigen), 1.6 u/μL T7 RNA polymerase, and 0.004 u/μL RNAse Inhibitor 
(Molox). DNA products and RNA products were verified by agarose gel electrophoresis and 
urea polyacrylamide gel electrophoresis, respectively. 
mRNA was purified by ion exchange chromatography over a 5 mL HiTrap HP SP column (GE 
Healthcare). The column was charged with 10 mL buffer FB (1.5 M NaCl) and equilibrated with 
buffer FA (300 mM NaCl). A gradient from 300 mM to 1.5 M NaCl was run over 100 mL. 
Fractions of 2 mL were collected; mRNA eluted at approximately 40% buffer FB. Fractions 
containing mRNA were identified by A260 peaks and precipitated overnight at -20°C in 1/10 
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volume potassium acetate and 2.5x volume ice-cold ethanol. Precipitated mRNA was pelleted 
at 4000 xg for 1 hour at 4°C and resuspended in nuclease-free water. Final concentration of 
the mRNA was  calculated using the equation 𝐴=𝜀∗𝑏∗𝑐, where 𝐴 is A260, 𝜀 is the extinction 
coefficient of the mRNA (1232.5 mM-1cm-1, predicted using the Extinction Coefficient 
Calculator, The Scripps Research Institute), 𝑏 is the path length (1 cm), and 𝑐 is the 
concentration. 
For the translation reaction, 70S ribosomes from E. coli strain MRE600, initiation factors, EF-
Tu, EF-G,  RRF, RF3, f[3H]Met-tRNAfMet, [14C]Phe-tRNAPhe, and [14C]Phe-tRNAPhe(Flu) were 
prepared as previously described (Milon et al., 2007; Rodnina and Wintermeyer, 1995) by 
Sandra Kappler, Olaf Geintzer, Cristina Kothe, and Michael Zimmermann. Stalled ribosome 
complexes were prepared by translating the first two codons on the mRNA. To initiate 
translation, 70S ribosomes were mixed with a 1.5 fold excess of initiation factors, 3 fold excess 
f[3H]Met-tRNAfMet, and 3 fold excess mRNA in HAKM7 buffer (50 mM HEPES, 30 mM KCl, 70 
mM NH4Cl, 7 mM MgCl2, pH 7.4) supplemented with 1 mM dithiothreitol (DTT) and 1 mM GTP. 
This mixture was incubated for 45 min at 37°C. 3 pmol ribosomes were filtered over 
nitrocellulose filters and quantified by scintillation counting to assess initiation efficiency, 
which was >90% for all mRNA lengths. Ternary complexes were formed for 15 min at 37°C 
with 3 fold excess of [14C]Phe-tRNAPhe over ribosomes and 1.5 µM EF-G, and 2 fold excess of 
EF-Tu pre-incubated with 1 mM GTP, 3 mM phosphoenolpyruvate (PEP), and 0.5 mg/mL 
pyruvate kinase in HAKM7 buffer. For fluorescence-labeled ribosomal complexes used in FRET 
experiments, fluorescein-labeled tRNA ([14C]Phe-tRNAPhe(Flu), provided by Olaf Geintzer) was 
used. 
Initiation complexes (IC) were mixed with 3x fold ternary complexes (TC) according to Phe-
tRNAPhe concentration. Dipeptide formation occurred for 2 min at room temperature. All 
ribosomes, regardless of the length of the associated mRNA, were supplied with the same 
ternary complex so that the P site was occupied by a radiolabeled dipeptidyl-tRNA. 
Consequently, varying lengths of mRNA extend past the P site to form P+0 complexes (0 
nucleotides past the P-site) and P+n complexes (n = 3, 6, 9, 12, 15, 24, 30, 99). Complexes were 
purified by ultracentrifugation for 2 hours at 55,000 rpm (Optima MAX XP Ultracentrifuge, 
TLS-55 rotor, Beckman Coulter) over a cushion of 1.1 M sucrose in HAKM20 buffer (HAKM7 
buffer containing 20 mM MgCl2). The pellets were resuspended in HKM7 buffer (HAKM7 buffer 
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without NH4Cl) and quantified by liquid-liquid scintillation counting, then flash frozen and 
stored at -80°C. Dipeptide formation under these conditions was > 80%.  
3.2.3 Pre-steady state hydrolysis assays 
All experiments were performed in HKM7 buffer (50 mM HEPES, 30 mM KCl, 7 mM MgCl2, pH 
7.4). Single round peptidyl-tRNA hydrolysis reactions were monitored by rapidly mixing P+0 
complexes and ArfB in a quenched-flow apparatus at 37°C and by hand at 20°C. For the 
quenched-flow experiments, equal volumes of P+n complex (0.3 µM) and ArfB (0.4, 0.6, 0.9, 
1.2, 3, 4 µM) were rapidly mixed in the appropriate reaction loop. At the desired time point, 
the reaction was quenched with a solution of 10% trichloroacetic acid (TCA) and 50% ethanol. 
The samples were kept on ice for 30 min, then the precipitated ribosomes and peptidyl-tRNA 
were spun down for 15 min at 16,000 x g at 4°C. The supernatant, which contains released 
peptides, were quantified by liquid-liquid scintillation counting. For each time course, 15-18 
time points were sampled. The resulting radioactivity counts were plotted against the 
corresponding reaction time, and the curve was fit with a one exponential or two exponential 
equation. The two exponential function is as follows: 
𝑓(𝑥) = 𝐴 + 𝐵 ∗ 𝑒𝑥𝑝−𝑐𝑥  + 𝐷 ∗  𝑒𝑥𝑝−𝑒𝑥 
Where 𝐴 is the final plateau, 𝐵 is the amplitude of the first phase, 𝑐 is the rate constant of the 
first phase, 𝐷 is the amplitude of the second phase, and 𝑒 is the rate constant of the second 
phase. The one exponential function is as follows: 
𝑓(𝑥) = 𝐴 ∗ (1 −  𝑒𝑥𝑝−𝑏𝑥) 
where 𝐴 is the final plateau and 𝑏 is the rate constant. All hydrolysis time courses were 
normalized by the plateau extrapolated from the exponential fit to give the fraction of peptide 
released at each time point. 
3.2.4 Steady state hydrolysis assays 
Endpoint peptidyl-tRNA hydrolysis assays were performed by mixing stalled ribosome 
complexes with 10 fold excess of release factor (ArfB or ArfBGAQ, where applicable) at 37°C. 
The reactions were quenched and released peptides were quantified with the method 
described above. 
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Multiple turnover peptidyl-tRNA hydrolysis was measured at 20°C and 37°C by incubating ArfB 
with at least 10 fold excess of stalled ribosomal complex. ArfB concentration was 0.02 µM for 
P+0 complexes and 0.05 µM for P+9 complexes. At each time point, an aliquot of the mixture 
was quenched as described above. At each stalled ribosomal complex concentration, the 
linear fit of the time course gave the initial velocity of the reaction. Background peptide 
dropoff, measured in a parallel reaction without ArfB, was subtracted. Michaelis-Menten 
constants KM and kcat were calculated from the hyperbolic fit of initial velocity plotted against 
substrate concentration.  
The effect of translation factors on ArfB turnover was assayed by measuring initial velocity in 
the presence of 0.5 µM ribosome recycling factors RRF and EF-G. Because subunit splitting is 
a GTP-dependent process, the HKM7 buffer was supplemented with 3 mM PEP, 1 mM GTP or 
GTP-ƴS, and 1 mg/mL pyruvate kinase. 
3.2.5 Competition between ArfB and ternary complex 
The effect of ternary complex on ArfB-mediated ribosome rescue was measured by 
simultaneously incubating 0.5 µM P+3 or P+33 complex (ribosomes initiated on an mRNA with 
two codons, with phenylalanine as the second, untranslated codon) with ArfB and cognate 
ternary complex of EF-Tu – GTP – [14C]Phe-tRNAPhe (0.25 µM). After incubation at 37°C for 20 
and 120 s, two aliquots were taken. One was quenched with 0.1 x sample volume 5M 
potassium hydroxide (KOH) then hydrolyzed for 30 min at 37°C for subsequent quantification 
of dipeptide formation. The other was quenched in a solution of 10% TCA and 50% EtOH for 
quantification of released [3H]fMet, using the protocol described in section 3.2.3. 
Dipeptides were quantified using a previously published protocol (Doerfel et al., 2013). Briefly, 
the samples quenched with KOH were neutralized with acetic acid and analyzed by reversed 
phase HPLC (Chromolith RP8 100-4.6 mm column, Merck), over a 0-65% acetonitrile gradient 
in 0.1% TFA. Fractions were analyzed by scintillation counting, with the fractions containing 
both 3H and 14C counts identified as dipeptide-containing fractions. Fraction dipeptide formed 
was calculated by normalizing the dipeptide peak with total amino acids detected, as 
calculated by the sum of all peaks. 
The effect of non-cognate ternary complex was assayed by measuring time courses of ArfB-
mediated peptidyl-tRNA hydrolysis on 0.5 µM P+3 and P+33 complexes at 37°C. Non-cognate 
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ternary complex (TC) was formed with 10 µM EF-Tu, 5 µM Val-tRNAVal, 0.5 mg/mL pyruvate 
kinase, 1.5 mM PEP, and 0.5 mM GTP. TC was mixed with an equal volume of purified P+0 IC 
or P+30 IC in the presence of 0.1 µM ArfB and 2 µM ArfB, respectively. To assess the effect of 
translocation on hydrolysis, 2 µM EF-G was also added to a set of samples. Aliquots were taken 
at time points up to 5 min, then processed as previously described to quantify the released 
peptides. The resulting curves were fit with a hyperbolic equation. 
3.2.6 Fluorescence labeling of ArfB 
Single-cysteine variants of ArfB, ArfB(K96C) and ArfB(R112C), were purified as described 
previously. Single-cysteine mutants were found to be identical to the wildtype in terms of 
hydrolytic activity, as shown by single-round hydrolysis reaction time courses. 
Fluorescence labeling was carried out using previously published protocols (Milon et al., 2007). 
Briefly, purified ArfB was exchanged into SA buffer without β-mercaptoethanol through a PD-
10 desalting column (GE Healthcare). 10x excess thiol-reactive fluorescent dye (fluorescein or 
ATTO-540Q) was then added to the protein drop-by-drop, and the mixture was incubated in 
the dark at room temperature for 2 hours. The labeling reaction was stopped by adding 1 µL 
1.4 M β-Mercaptoethanol. 
Free dye was removed using a PD-10 desalting column. Labeling efficiency, estimated by 
absorbance measurements of the dye by SDS-PAGE based protein concentration 
determination, was approximately 60% in most cases. 
3.2.7 Stopped-flow measurements of ArfB binding 
All stopped flow experiments were performed in HKM7 buffer, with an excitation wavelength 
of 465 nm and a KV500 cutoff filter (Schott), and using an SX-20MV stopped flow machine 
(Applied Photophysics, United Kingdom). For the association reaction, equal volumes of 
ArfB(540Q) and P+0(Flu) complex (P+0 complex with a fluorescein-labeled [14C]Phe-tRNAPhe in 
the ribosomal P site) were rapidly mixed at 20°C for a final concentration of 0.05 µM, 0.1 µM, 
0.2 µM, 0.3 µM, 0.4 µM, and 0.5 µM ArfB, and 0.015 µM P+0(Flu) complex. Fluorescence 
change upon FRET between the fluorescein dye on the P+0(Flu) complex and the ATTO(540Q) 
quencher was recorded over time. The resulting traces were fit with the three exponential 
equation:  
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𝑓(𝑥) = 𝐴 + 𝐵 ∗ 𝑒𝑥𝑝−𝑐𝑥 + 𝐷 ∗ 𝑒𝑥𝑝−𝑒𝑥 + 𝐹 ∗ 𝑒𝑥𝑝−𝑔𝑥 
Where 𝐴 is the final plateau, 𝐵, 𝐷, and 𝐹 are the amplitudes of each phase, and 𝑐, 𝑒, and 𝑔 
are the rate constants of each phase. Exponential fitting was performed using the GraphPad 
Prism software. 
Chase experiments were performed at 20°C to measure the dissociation rate (kOFF) of ArfB 
from the ribosome. For the post-hydrolysis dissociation reaction, 0.2 µM ArfB(540Q) was pre-
incubated with 0.03 µM P+0(Flu) complex for 5 min at 37°C, then rapidly mixed with an equal 
volume of 2 µM unlabeled P+0 complex. For the pre-hydrolysis dissociation reaction, 0.2 µM 
ArfBGAQ(540Q) was pre-incubated with 0.03 µM P+0(Flu) for 1 min at room temperature, then 
rapidly mixed with an equal volume of 2 µM unlabeled P+0 complex. Recovery of fluorescence 
following dissociation of the quencher-labeled ArfB variants was recorded over time. The 
resulting fluorescence traces were fit with the following two exponential equation using 
GraphPad Prism:  
𝑓(𝑥) = 𝐴 + 𝐵 ∗ 𝑒𝑥𝑝−𝑐𝑥 + 𝐷 ∗ 𝑒𝑥𝑝−𝑒𝑥 
Where 𝐴 is the final plateau, 𝐵 is the amplitude of the first phase, 𝑐 is the rate of the first 
phase, 𝐷  is the amplitude of the second phase, and 𝑒 is the rate of the second phase. All 
fluorescence traces were normalized by the highest level of fluorescence as extrapolated by 
the fit. 
3.2.8 Fluorimeter measurements of ArfB binding 
Binding affinity of ArfB for stalled ribosomes was measured by monitoring anisotropy in a 
spectrofluorometer (Horiba, Japan). The excitation wavelength was 465 nm and emission was 
measured at 520 nm, with slit width of 5 nm. Sub-stoichiometric amounts of P+0 complex 
were added to 10 nM ArfB(Flu) (ArfB labeled with fluorescein). At each data point, the cuvette 
was vortexed to ensure equilibrium was reached before measuring anisotropy. The anisotropy 
value at each point was the average of 10 measurements. The anisotropy value of the 
unbound protein was subtracted to obtain anisotropy change (Δ Anisotropy). Δ Anisotropy 
was plotted against P+0 concentration for an equilibrium binding curve, which was fit with a 
hyperbolic equation: 
𝑓(𝑥) = (𝐴 ∗ 𝑥)/(𝐾𝑑 + 𝑥) 
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Where 𝐴 is the maximal binding and 𝐾𝑑 is the concentration of ligand required to reach half-
maximal binding. 
To assess the effect of salt concentration on ArfB binding, 50 nM ArfB(Flu) was mixed with 150 
nM P+0 complexes in HK50M7 buffer (HKM7 buffer with 50 mM KCl). Then, KCl or MgCl2 was 
titrated into the sample, and the anisotropy value at each concentration was recorded. To 
account for light scattering caused by the ribosome, polarized light intensities of P+0 
complexes at each KCl or MgCl2 concentration were also subtracted. Anisotropy (𝑟) was then 
calculated using the equation: 
𝑟 =
𝐼𝑉𝑉 − 𝐺 ∗ 𝐼𝑉𝐻
𝐼𝑉𝑉 + 2𝐺 ∗ 𝐼𝑉𝐻
 
Where  𝐼𝑉𝑉  = intensity of vertically excited vertical emission, 𝐼𝑉𝐻  = intensity of vertically 





Where 𝐼𝐻𝐻  = intensity of horizontally excited horizontal emission, and 𝐼𝐻𝑉  = horizontally 
excited vertical emission. 
A titration of the unbound protein was performed in parallel and the anisotropy values 
subtracted to give an anisotropy change value at each salt concentration. The resulting curve 
was fit with the following equation: 
𝑓(𝑥) = 𝐴 + (𝐵 − 𝐴)/(1 + 10(log(𝐼𝐶50−𝑥)∗𝑘
1)) 
Where 𝐴 = minimum value; 𝐵 = maximum value; 𝑥 = log of total ion concentration in M; 𝐼𝐶50 
= inhibitory concentration corresponding to 50% of the amplitude change; 𝑘1  = Hill slope 
factor. 
Binding affinities were also measured using a FRET pair of the fluorescein on P+0(Flu) 
complexes, and the non-emitting fluorescence acceptor ATTO540Q on ArfB(540Q). Sub-
stoichiometric amounts of ArfB(540Q) were titrated into P+0(Flu) complexes, and 
fluorescence of the donor fluorophore was monitored by excitation at 488 nm and detection 
at 520 nm, with a slit width of 7 nm. The decrease in the fluorescence of fluorescein was 
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recorded using a spectrofluorometer. The resulting curve was fit with a quadratic equation to 
account for ligand depletion: 
𝑓(𝑥) = −[𝐴 + 𝐵 ∗  
𝐷 + 𝑥 + 𝐾𝑑 −  √(−𝐷 − 𝑥 − 𝐾𝑑)2 − 4 ∗ 𝐷 ∗ 𝑥 
2
] 
Where 𝐴 is the fluorescence at no binding, 𝐵 is the amplitude, 𝐷 is the ribosome complex 
concentration, and 𝐾𝑑 is the concentration of ligand required to reach half-maximal binding. 
3.2.9 Sample preparation for cryo-electron microscopy 
Cryo-electron microscopy samples were prepared using purified P+0 and P+9 complexes. 
Because complexes were purified over a sucrose cushion, traces of sucrose were removed 
from P+9 complexes using Zeba Spin Desalting Columns (7K MWCO, ThermoFisher). The 
complexes (0.4 µM) were then incubated with ArfB (1.5 µM) and Api137 (50 µM) for 10 min 
at 37°C. 
Cryo-EM analysis was performed by Claudia Müller (Institute for Biochemistry and Molecular 
Biology, University of Hamburg) and Niels Fischer (Department of Structural Dynamics, Max 
Planck Institute for Biophysical Chemistry). Data analysis and model construction were 
performed by Niels Fischer and Valentyn Petrychenko (Department of Structural Dynamics, 
Max Planck Institute for Biophysical Chemistry). 
3.2.10 Circular dichroism measurements 
Circular dichroism (CD) spectra of ArfB and ArfBNterm were measured at 20°C and 37°C with 
spectral scans from 180 nm to 260 nm, at 1 nm intervals in a Chirascan circular dichroism 
spectrometer (Applied Photophysics, UK) . ArfB and ArfBNterm were diluted to 8 µM in CD buffer 
(20 mM Na2HPO4, 100 mM NaF) for each measurement. 
3.2.11 Directed tag insertion in chromosomal ArfB 
Endogenous ArfB was enriched for mass spectrometry analysis by immunoprecipitation. A 
3xFLAG tag was inserted at the C terminus of chromosomally encoded ArfB using a previously 
published method (Link et al., 1997). Briefly, a segment of the E. coli BW25113 sequence 
containing the yaeQ-arfB-nlpE operon and 500 flanking base pairs were cloned into the pKOV 
vector using Gibson Assembly of three fragments.  The 3xFLAG tag (amino acid sequence 
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DYKDHDGDYKDHDIDYKDDDDK) was inserted at the C terminus by appending the sequence to 
the amplification primers. 
Gene replacement was performed in an electrocompetent BW25113 strain. The pKOV vector 
carrying the modified arfB gene was transformed into BW25113 cells using electroporation, 
then grown overnight at 30°C. The resulting cells were re-plated on LB agar supplemented 
with chloramphenicol and incubated overnight at 43°C for plasmid integration, then again 
incubated overnight at 30°C on LB agar supplemented with sucrose (5% w/v, no NaCl) for 
plasmid excision. Replica plating was performed on LB agar plates supplemented with 
chloramphenicol to screen for loss of the plasmid. Positive clones were confirmed by PCR. 
3.2.12 Immunoprecipitation of endogenous ArfB 
The E. coli strain containing 3xFLAG-tagged chromosomal arfB was cultured until O.D. 0.6 (log-
phase), and the cells were stored by flash-freezing in liquid nitrogen. Cells were thawed in 
sonication buffer supplemented with protease inhibitor (cOMPLETE EDTA free, 1 tablet per 50 
mL buffer) and DNaseI (10 µL per 50 mL buffer). Lysis was performed by sonicating on ice for 
10 min at 25% amplitude, 10 s pulse with 10 s break. The lysate was clarified by centrifugation 
at 35,000 g for 30 min. The supernatant was flash-frozen and stored for further steps. 
3xFLAG-tagged ArfB was enriched using anti-FLAG M2 beads. The beads were equilibrated in 
AFC buffer supplemented with 1 protease inhibitor tablet per 50 mL buffer. 10% Triton X-100 
was added to the clarified lysate for a final concentration of 0.1%, then the lysate was the 
incubated with 100 µL anti-FLAG M2 beads for 1 hour at 4°C while rotating. The beads were 
washed with a total of 1 mL AFC buffer, then bound proteins were eluted by incubating for 3 
min at 95°C in SDS sample buffer without reducing agents. The eluted proteins were loaded 
on 4-20% SDS-PAGE gradient gels (BioRad), and bands corresponding to the size of ArfB (14 
kDa) were excised for mass spectrometry analysis. 
3.2.13 Targeted mass spectrometry 
Isolated endogenous ArfB was digested using the protease ArgC in order to obtain a peptide 
containing the GGQ motif. Targeted mass spectrometry analysis was performed using the Q 
Exactive HF (Thermo Fischer); data analysis was carried out in the software Skyline (University 
of Washington, USA) by Dr. Ingo Wolgemuth (Department of Physical Biochemistry, Max 





4.1 Substrate specificity of ArfB 
The issue of substrate specificity of ArfB can be simplified to one of the interplay between ArfB 
and mRNA extending past the ribosomal P site. In the case of ribosomes stalled on truncated 
mRNAs, the A site is unoccupied by aminoacyl-tRNA, and the mRNA entry channel is empty. 
In the case of ribosomes stalled on rare codon clusters, however, the A site may still be 
unoccupied due to a lack of cognate ternary complex corresponding to the rare codon in 
question, but the mRNA in the mRNA entry channel extends beyond the P site. According to 
biochemical studies using purified ArfB and stalled ribosomes assembled in the PURE system, 
ArfB can resolve the latter type of stalling (Handa et al., 2011). 
To accurately measure the activity of ArfB on ribosomes stalled in the middle of mRNAs, we 
purified ribosomal complexes stalled on mRNAs of varying length, translating only the first 
two codons so all ribosomal complexes would have the same radioactive fMet-Phe dipeptide 
in the P site, but have increasing lengths of mRNA extending past the P site (Figure 4.1a).This 
was achieved by providing only the ternary complexes for the first codon in the translation 
reaction. We then proceeded to measure the effect of mRNA length on the ArfB-mediated 
peptidyl-tRNA hydrolysis reaction (Figure 4.1b). 
 
Figure 4.1. Schematic of the single-round hydrolysis experiment. (a) P+n complexes. (b) P+n 






4.1.1 Single-round ArfB-mediated hydrolysis on P+n complexes 
We measured pre-steady state time courses of ArfB-mediated peptidyl-tRNA hydrolysis on 
stalled ribosomes with increasing lengths of mRNA extending past the P site. Using the 
quenched flow apparatus, we rapidly mixed excess ArfB with P+n complexes (n = 0, 3, 6, 9, 12, 
15, 24, 30, 99 nucleotides extending past the ribosomal P site). The resulting curves were fit 
with single-exponential equations (Figure 4.2a), which in turn gave the apparent rate constant 
of the hydrolysis reaction (khydrolysis). 
 
Figure 4.2. ArfB preferentially hydrolyzes peptidyl-tRNA on stalled ribosomes with less than 6 
nucleotides extending past the P site. (a) Time course of single-round peptidyl-tRNA hydrolysis. 
P+n complexes (0.15 µM) were rapidly mixed with ArfB (1 µM). Error bars represent the range 
of values of two biological replicates. (b) The apparent rate of peptidyl-tRNA hydrolysis on P+n 
complexes. Error bars show the standard error of the fit. 
The apparent rate constant of the single-round hydrolysis reaction decreases dramatically on 
stalled ribosomes with more than 6 nucleotides extending past the P site, decreasing by more 
than 2 fold from P+0 to P+9 complexes (Figure 4.2b). On P+99 complexes, hydrolysis occurs at 
approximately 0.0016 s-1, two orders of magnitude slower than on of P+0 complexes 
(approximately 0.15 s-1). It is worth noting that while slow, the hydrolysis reaction still reaches 
saturation after more than 20 min incubation, which is in line with previous reports of steady-
state measurements that show ArfB-mediated rescue of ribosomes stalled on longer mRNAs 
(Handa et al., 2011). Our pre-steady state measurements, however, show that this hydrolysis 






4.1.2 Competition between ArfB and cognate ternary complex 
The slow rate of ArfB-mediated peptidyl-tRNA hydrolysis calls into question whether its 
activity on ribosomes stalled on longer mRNAs is physiologically relevant. With a codon 
presented in the A site, there are A-site binding translation factors that may compete with 
ArfB for a binding site, with the most abundant being elongation factor EF-Tu (Jacobson and 
Rosenbusch, 1976). To test if this affects ArfB activity, we performed competition experiments 
to measure ArfB-mediated hydrolysis in the presence of cognate ternary complex (TC) EF-Tu 
– GTP – [14C]Phe-tRNAPhe. 
We incubated P+3 or P+33 complex with ArfB and TC simultaneously, and monitored dipeptide 
formation and fMet release at concurrent time points (Figure 4.3a). Unlike those used in 
previously described single-round hydrolysis experiments, the ribosomal complexes were 
stalled with a single [3H]fMet-tRNAMet in the ribosomal P site. The ternary complex was formed 
with [14C]Phe-tRNAPhe, in cognate to the A-site codon on the stalled ribosomal complexes. We 
find that dipeptide formation dominates when ArfB concentration is low, with over 50% 
dipeptide formation as opposed to less than 40% fMet release at 20 and 120 s, levels 
consistent with control experiments where no ArfB was added (Figure 4.3b). At high ArfB 
concentration, however, fMet hydrolysis is the dominant reaction on P+3 complexes (Figure 
4.3c). Furthermore, we also find that dipeptide formation is the main reaction occurring on 






Figure 4.3. Cognate ternary complex competes with ArfB. (a) Schematic of the competition 
experiment. P+n complexes are mixed with both ArfB and cognate ternary complex, and 
dipeptide formation and fMet release are quantified. (b) Dipeptide formation on P+n 
complexes (0.5 µM) in the presence of ArfB (0.3 or 2 µM) and cognate ternary complex EF-Tu-
GTP-[14C]Phe-tRNAPhe (0.25 µM). (c) ArfB-mediated fMet release on P+33 complexes in the 
presence of cognate ternary complex. Error bars indicate the range of values of two biological 
replicates. 
This experiment shows that in the presence of cognate ternary complex, ArfB-mediated 
peptidyl-tRNA hydrolysis is precluded on ribosomes stalled in the middle of an mRNA. As ArfB 
expression levels are low under experimentally tested conditions (Schmidt et al., 2016; 
Taniguchi et al., 2010), it seems unlikely that the ArfB rescue pathway can compete with 
translation elongation, even on ribosomes with only 3 nucleotides extending past the P site. 
4.1.3 Competition between ArfB and non-cognate ternary complex 
In the case of ribosomes stalled on rare codon clusters, cognate ternary complexes are by 
definition scarce, whereas non-cognate ternary complexes (where the associated aminoacyl-
tRNA does not correspond to the codon presented in the ribosomal A site) may still transiently 




TC can affect ArfB-mediated ribosome rescue, we performed peptidyl-tRNA hydrolysis time 
courses in the presence of non-cognate ternary complex EF-Tu – GTP – Val-tRNAVal.  
We incubated P+3 and P+33 with ArfB and non-cognate ternary complex which was formed 
with Val-tRNAVal (Figure 4.4a) The codon presented in the ribosomal A site encoded Phe, and 
a higher ArfB concentration was selected for P+33 to ensure a readout that could be reliably 
quantified. fMet release was monitored over time. The resulting curves overlap under all 
conditions, indicating that the presence of non-cognate ternary complex does not affect ArfB-
mediated peptidyl-tRNA hydrolysis, regardless of mRNA length (Figure 4.4b and Figure 4.4c). 
 
Figure 4.4. Non-cognate ternary complex does not affect ArfB-mediated ribosome rescue. (a) 
Schematic of the competition experiment. P+n complexes are mixed with both ArfB and non-
cognate ternary complex, and fMet release is quantified. fMet release at 37°C in the presence 
of ternary complex (TC, 10 µM EF-Tu, 5 µM Val-tRNAVal, 0.5 mM GTP) on  (b) P+3 complexes 
(0.5 µM) incubated with ArfB (0.1 µM) and (c) P+33 complexes (0.5 µM) incubated with ArfB 






4.1.4 Mechanism of inhibition by mRNA 
To understand how mRNA in the mRNA entry channel inhibits ArfB-mediated ribosome rescue, 
we performed Michaelis-Menten titrations to determine the values of the constants KM and 
kcat. Time courses of ArfB-mediated peptidyl-tRNA hydrolysis were measured at increasing 
concentrations of P+0 and P+9 complex. P+9 complex was chosen because it was shown to be 
the mRNA length at which the apparent rate of hydrolysis significantly decreased, but is still 
reliably quantifiable by our methods. 
The resulting curves were fit with hyperbolic equations, from which we could compute KM, or 
the concentration at which the reaction velocity reaches its half-maximum value. The KM for 
P+0 is 0.25 ± 0.09 µM, and kcat, the maximum velocity of the reaction divided by total ArfB 
concentration, is approximately 0.01 s-1 (Figure 4.5a). We could not titrate the curve for P+9 
to saturation, due to the infeasibility of using ribosomal complexes at concentrations higher 
than 2 µM; the specificity constant kcat/KM is therefore reported (Figure 4.5b). 
 
Figure 4.5. mRNA inhibits ArfB-mediated ribosome rescue. (a) Michaelis-Menten curve of 
ArfB-mediated peptidyl-tRNA hydrolysis on P+0 complexes. ArfB (0.02 µM) was incubated 
with increasing concentrations of P+0 complex. (b) Michaelis-Menten curve of ArfB-mediated 
peptidyl-tRNA hydrolysis on P+9 complexes. ArfB (0.05 µM) was incubated with increasing 
concentrations of P+9 complex. Error bars represent the SEM of three biological replicates. 
kcat/KM, called the “specificity constant”, can be used to compare the two substrates P+0 and 
P+9. For P+0, the specificity constant is 0.04 s µM-1, whereas for P+9 it is 0.003 s µM-1. This 
approximately 13 fold difference shows that ArfB is more specific for P+0 than for P+9. The 
low kcat, however, also shows that ArfB is a catalytically inefficient enzyme, with its turnover 




4.1.5 Effect of recycling factors on ArfB turnover 
The low kcat of ArfB creates an interesting conundrum regarding its physiological role. Under 
experimentally tested conditions, the expression of ArfB in E. coli is very low (Taniguchi et al., 
2010), and while the low cellular concentration can be compensated for by high binding 
affinity, the slow turnover would make ArfB a very inefficient release factor. The question 
remains if there are factors that assist ArfB dissociation and accelerate turnover. To answer 
this question, we tested known factors associated with ribosome recycling using turnover 
assays. 
While the detailed mechanism is still under debate, it is known that EF-G and RRF together 
facilitate the dissociation of deacylated tRNA and mRNA, as well as ribosome splitting (Gao et 
al., 2005; Peske et al., 2005). We therefore performed the initial velocity measurements 
described in section 4.1.4 in the presence of EF-G and RRF. 
When the buffer was supplemented with GTP, we observe a moderate increase in initial 
velocity with EF-G and RRF present (Figure 4.6a). The addition of EF-G and RRF individually 
also produced an increase in initial velocity to a lesser extent. The same trend is observed in 
an experiment where the buffer was supplemented with the slow-hydrolyzing GTP analog 
GTP-γS (Figure 4.6b). In the absence of nucleotide altogether, the additions of EF-G and RRF 
also increase initial velocity to a small degree (Figure 4.6c). 
By taking the concentration of peptides released at the 5-min time point and dividing it by the 
enzyme concentration, we calculate the average number of times each ArfB molecule 
hydrolyzed the dipeptide (Figure 4.6d). The addition of RRF and EF-G increases this number 
by almost 30%. This suggests that the presence of ribosome recycling machinery moderately 






Figure 4.6. Recycling factors accelerate ArfB turnover. ArfB (0.02 µM) was incubated with P+0 
complex (0.2 µM) in the presence of RRF (0.5 µM) and EF-G (0.5 µM) in the presence of (a) 
GTP (1 mM), (b) GTP-γS, and (c) no nucleotide. Solid lines represent the linear fit of the time 
course, and error bars represent the SEM of three independent experiments. (d) Number of 






4.2 Initial binding of ArfB 
The crystal structure of ArfB shows the C-terminal tail occupying the mRNA entry channel, 
which should clash with mRNA extending past the P site (Gagnon et al., 2012). This suggests 
that the specificity of ArfB for ribosomes stalled on truncated mRNA may arise from binding. 
To evaluate the effect of mRNA on ArfB interactions with the ribosome, we developed a 
Förster resonance energy transfer (FRET) pair to report on binding events (Lakowicz, 1988). 
Briefly, FRET occurs between an excited donor fluorophore and an acceptor fluorophore when 
they come into a close distance that is comparable to the size of proteins (30 – 60 Å). The 
fluorescence change of the donor fluorophore and of the acceptor fluorophore therefore 
reports on changes of distance between two labeled proteins. We labeled stalled ribosomal 
complexes with a donor fluorophore, and attached an acceptor fluorophore to ArfB to directly 
monitor ArfB binding over time (Figure 4.7). 
 
Figure 4.7. Schematic of the ArfB binding experiment. Fluorescein-labeled P+n complexes are 
rapidly mixed with ATTO-540Q-labeled ArfB and fluorescence change is monitored over time. 
4.2.1 Activity of labeled ArfB and ribosomal complexes 
We prepared P+0, P+9, and P+30 complexes with [14C]Phe-tRNAPhe(Flu), which is labeled with 
fluorescein on position 8 of the tRNAPhe. This resulted in stalled ribosomal complexes with a 
fluorescent P-site tRNA. ArfB was labeled with the fluorescence quencher ATTO-540Q on 
positions 96 and 112, on the globular N-terminal domain and the C-terminal tail, respectively. 
The activity of the labelled ArfB and ribosomal complexes was tested by single-round peptide 
release as described in section 4.1.1. All the components show comparable activity to their 
wild-type counterparts (Figure 4.8a, Figure 4.8b). We can therefore use fluorescence-labeled 






Figure 4.8. The activity of fluorescence-labeled P+0 complex and quencher-labeled ArfB is 
comparable to unlabeled, wild-type components. (a) ATTO-540Q labeled ArfB(K96C) and 
ArfB(R112C) (1 µM) have similar activity (khydrolysis = 0.14 ± 0.01 s-1 for both variants) on P+0 
complexes (0.15 µM) as unlabeled wild-type (WT) ArfB (khydrolysis = 0.23 ± 0.02 s-1) in the single-
round hydrolysis time course. (b) P+0 complex (0.15 µM) with a fluorescein-labeled P site tRNA 
(P+0(Flu)) has a similar activity (khydrolysis = 0.40 ± 0.02 s-1) as the unlabeled complex in the 
hydrolysis reaction with ArfB (1 µM). 
4.2.2 Activity of the hydrolysis-deficient ArfB mutant 
To measure ArfB binding to pre-hydrolysis P+n complexes, we used a hydrolysis-deficient 
variant in some binding experiments. Previous studies have shown that mutating the second 
residue in the catalytically active GGQ motif can reduce the hydrolytic activity of ArfB (Chadani 
et al., 2011b). We therefore purified ArfBGAQ, where Gly 27 is mutated to Ala. 
The hydrolytic activity of the hydrolysis-deficient variant was tested by incubating ArfBGAQ with 
stalled ribosomal complex at 37°C (Figure 4.9a). ArfBGAQ is active on all complexes at 37°C, to 
the extent that after 40 min incubation, at least 25% of P+30 complex will be in the post-
hydrolysis state, creating heterogeneous conditions that would make interpretation of binding 
experiments difficult. 
We then repeated the time courses of peptidyl-tRNA hydrolysis on P+0 complexes at 20°C. 
P+0 was incubated with ArfBGAQ or ArfB (Figure 4.9b). The results show that at 20°C, peptidyl-
tRNA hydrolysis by ArfBGAQ is comparable to that of the background where no ArfB was added 
for up to 2 hours. Using ArfBGAQ at this temperature, we are able to measure ArfB binding to 





Figure 4.9. Hydrolytic activity of ArfBGAQ. (a) Time courses of peptidyl-tRNA hydrolysis by 
ArfBGAQ (1 µM) on P+0, P+9, and P+30 (0.1 µM) complexes at 37°C. (b) Peptidyl-tRNA hydrolysis 
by ATTO-540Q labeled ArfB(K96C) and ArfBGAQ(K96C) (1 µM) on P+0 complexes (0.1 µM) at 
20°C. 
4.2.3 Binding of ArfBGAQ to ribosomes in real time 
To measure the binding of ArfB to ribosomes in real time, we rapidly mixed quencher-labeled 
ArfBGAQ(K96C) with P+0(Flu) in the stopped flow apparatus at 20°C. Upon ArfB binding, the 
two fluorescent dyes come into close contact and the fluorescence of the donor fluorophore, 
fluorescein, is quenched by the acceptor fluorophore, ATTO-540Q. The decrease in donor 
fluorescence over time reports on the binding of ArfB. 
At 20°C, ArfB binds to the ribosome very rapidly, so that at higher concentrations of ArfB, the 
reaction occurs in the dead-time of the stopped flow (1 – 1.5 ms) (Figure 4.10a). The 
fluorescence traces of the binding reaction can be described with three exponents, suggesting 
a multi-step interaction following initial binding, or that we are monitoring more than a single 
binding event. By plotting the apparent rate constants against ArfB concentration, we 
determine the rate-concentration relationship for each exponent (Figure 4.10b). The apparent 
rate of the three phases show a linear dependence on ArfB concentration, which is a hallmark 
of bimolecular association reactions, indicating that the three phases most likely do not show 
consecutive steps on a multistep pathway. The slope given by the linear fit of apparent rates 
is the kON of each phase, while the y-intercept gives the kOFF (Table 4.1). For the first phase, 
which is also the dominant phase according to its amplitude, the kON is 960 ± 70 µM-1 s-1; the 




affinity Kd, calculated from the ratio of koff/kon, is 45 ± 18 nM for the majority of molecules in 
the population. 
 
Figure 4.10. ArfBGAQ binds to P+0 complexes rapidly. (a) Time courses of quencher-labeled 
ArfBGAQ(K96C) (0.05-0.5 µM) binding to P+0(Flu) (0.015 µM) at 20°C. (b) Apparent rate 
constants of ArfB binding to P+0 complexes, derived from the three exponential fit of the 
binding traces. Error bars represent the range of values of two independent experiments.  
Table 4.1. Association and dissociation rates of ArfBGAQ to P+0 complexes 
 kapp1 kapp2 kapp3 
kON, µM-1 s-1 960 ± 70 130 ± 10 17 ± 2 
kOFF, s-1 43 ± 16 n.s. n.s. 
 
Association and dissociation rate constants were obtained from the linear fit of the 
concentration dependence of each apparent rate. Errors are SEM of the fit. 
4.2.4 Binding of ArfB to P+0 complexes 
Because the binding is very rapid compared to the rate of hydrolysis, we then performed the 




resulting traces can be described with three exponents, with the rate constants exhibiting a 
similar linear dependence on ArfB concentration as with ArfBGAQ (Figure 4.11b, Table 4.2). For 
the first exponent, the kON is 470 ± 40 µM-1 s-1, and the kOFF is 110 ± 20 s-1. The calculated Kd is 
approximately 230 ± 46 nM. 
 
Figure 4.11. ArfB binds to P+0 complexes rapidly. (a) Time courses of quencher-labeled 
ArfB(K96C) (0.05-0.5 µM) binding to P+0(Flu) (0.015 µM) at 20°C. (b) Apparent rate constants 
of ArfB binding to P+0 complexes, derived from the three exponential fit of the binding traces. 
Error bars represent the range of values of two independent experiments. 
Table 4.2. Association and dissociation rates of ArfB to P+0 complexes 
 kapp1 kapp2 kapp3 
kON, µM-1 s-1 470 ± 40 120 ± 10 1.0 ± 0.2 
kOFF, s-1 110 ± 20 n.s. n.s. 
 
Association and dissociation rate constants were obtained from the linear fit of the 





4.2.5 Binding of ArfB to P+9 and P+30 complexes 
To understand whether the mRNA in the mRNA entry channel affects ArfB binding, we 
performed binding assays with P+9(Flu) and P+30(Flu) (Figure 4.12a and Figure 4.12b). The 
resulting traces can be described with three exponential terms, and the apparent rates show 
linear dependence on ArfB concentration (Figure 4.12c). For P+9(Flu) complexes, the kON is 
280 ± 30 µM-1 s-1, and the kOFF is 140 ± 10 s-1. For P+30(Flu) complexes, the kON is 320 ± 40 µM-
1 s-1, and the kOFF is 120 ± 10 s-1. The results suggest that binding is also rapid on ribosomes 
stalled on longer mRNAs, and the association rate constant does not change significantly 
between the different complexes. Notably, the second and third apparent rate constants also 
show a linear dependence on ArfB concentration (Figure 4.12d, Table 4.3). This is an indication 
that instead of a single binding event followed by a series of conformational changes, we could 





Figure 4.12. ArfB binds to P+9 and P+30 complexes rapidly. (a) Time courses of quencher-
labeled ArfB(K96C) (0.05-0.5 µM) binding to P+9(Flu) (0.015 µM) at 20°C. (b) Time courses of 
quencher-labeled ArfB(K96C) (0.05-0.5 µM) binding to P+30(Flu) (0.015 µM) at 20°C. (c) 
Concentration dependence of the first apparent rate constant, derived from the three 
exponential fit of the binding traces. (d) Concentration dependence of the second and third 
rate constants, derived from the three exponential fit of the binding traces. Error bars 







Table 4.3. Association and dissociation rates of ArfB to P+0, P+9, and P+30 complexes 
 P+0 P+9 P+30 
Fast kON, µM-1 s-1 470 ± 70 280 ± 30 320 ± 40  
Fast kOFF, s-1 110 ± 20 140 ± 10 120 ± 10 
Medium kON, µM-1s-1 94 ± 4 84 ± 20 80 ± 13 
Medium kOFF, s-1 7.0 ± 1.2 0.8 ± 6 2.5 ± 3.2 
Slow kON, µM-1 s-1 0.7 ± 0.1 0.06 ± 0.01 1.8 ± 0.5 
Slow kOFF, s-1 0.4 ± 0.1 0.3 ± 0.1 n.s. 
 
Association and dissociation rate constants were obtained from the linear fit of the 
concentration dependence of each apparent rate. Errors are SEM of the fit. 
4.2.6 Effect of magnesium ions on initial binding 
Diffusion-limited association rate constants, especially with highly charged proteins such as 
ArfB, often indicate a strong electrostatic component in the binding reaction (Schreiber and 
Fersht, 1996; Wendt et al., 1997). To study whether this is also true for the ArfB-ribosome 
interaction we performed initial binding experiments at three concentrations of Mg2+. We 
chose Mg2+ because it was previously shown to have a strong effect on the alternative binding 
interaction between IF3 and the large ribosomal subunit (Goyal et al., 2017). 
We measured fluorescence change upon rapid mixing of P+n(Flu) with quencher-labeled 
ArfB(K96C) at 7 mM, 20 mM, and 30 mM MgCl2 (Figure 4.13a, b, and c). Rapid binding of ArfB 
is still observed at high magnesium concentrations across all three ribosomal complexes. The 
traces were fit with three exponents, and the apparent rate constant of the fast, major phase 
was plotted against magnesium concentration (Figure 4.13d). Increased Mg2+ concentration 
does not cause a significant decrease in the rate of initial binding, which suggests that 





Figure 4.13. Magnesium ions decreases the rate of ArfB initial binding. Time courses of 
quencher-labeled ArfB(K96C) (0.2 µM) binding to (a) P+0(Flu) (0.015 µM), (b) P+9(Flu) (0.015 
µM), and (c) P+30(Flu) (0.015 µM) at 20°C and increasing Mg2+ concentrations (7, 20, and 30 
mM). (d) Effect of Mg2+ on the first apparent rate constant, obtained from the three 
exponential fit of the binding traces. Error bars represent the range of values from two 
independent experiments. 
4.2.7 Dissociation of ArfB from stalled ribosomes 
In addition to the association rate constant, our FRET-based stopped flow experimental 
system allowed us to directly monitor the dissociation of ArfB from the ribosome. This was 
achieved by pre-incubating ArfB with P+0(Flu), then rapidly mixing in a large excess of 
unlabeled P+0. The dissociation of ArfB from P+0(Flu) over time is recorded as the recovery of 
donor fluorescence. 
For dissociation from pre-hydrolysis complexes, quencher-labeled ArfBGAQ(K96C) was pre-
incubated for 10 min at 20°C with P+0(Flu), and the resulting trace can be fit with a two-
exponential equation (Figure 4.14). The two apparent rates are 0.41 ± 0.01 s-1 and 0.04 ± 0.01 
s-1. For dissociation from post-hydrolysis complexes, ArfB(K96C) was pre-incubated for 10 min 




experiment. The resulting trace was fit with a two-exponential equation (Figure 4.14).  The 
apparent rates of dissociation are 0.86 ± 0.02 s-1 and 0.04 ± 0.01 s-1. 
 
Figure 4.14. Dissociation of ArfB from P+0 complexes. Quencher-labeled ArfB(K96C) or 
ArfBGAQ(K96C) (0.1 µM) was pre-incubated with P+0(Flu) (0.1 µM) then rapidly mixed with P+0 
(1 µM). 
The effect of mRNA length on dissociation was measured on pre-hydrolysis complexes by 
chasing quencher-labeled ArfBGAQ(K96C) from P+0(Flu), P+9(Flu), and P+30(Flu) complexes. 
The resulting traces can be fit with two-exponential equations (Figure 4.15). For P+9(Flu), the 
rates are 0.41 ± 0.01 s-1 and 0.07 ± 0.01 s-1. For P+30(Flu), the rates are 0.47 ± 0.02 s-1 and 0.10 
± 0.01 s-1 (Table 4.4). 
 
Figure 4.15. Dissociation of ArfB from P+n complexes. Quencher-labeled ArfBGAQ(K96C) (0.1 
µM) was pre-incubated with P+0(Flu), P+9(Flu), P+30(Flu) (0.1 µM) then rapidly mixed with 





While the dissociation traces are fit with more than one exponent, we can calculate the 
average rate of dissociation kavg using the following equation: 
𝑘𝑎𝑣𝑔 = 𝑘1 ∗ 𝐴1 + 𝑘2 ∗ 𝐴2 + ⋯ + 𝑘𝑛 ∗ 𝐴𝑛 
Where 𝑘𝑛  is the apparent rate of one exponent, and 𝐴𝑛  is the amplitude of the same 
exponent expressed in fractions of the total amplitude. The resulting average dissociation 
rates are as shown below in Table 4.4. 
Table 4.4. Dissociation rates of ArfB. 
 kapp1, s-1 A1 kapp2, s-1 A2 kavg 
P+0 (post-hydrolysis) 0.86 ± 0.01 0.43 ± 0.01 0.04 ± 0.01 0.57 ± 0.01 0.39 ± 0.01 
P+0 (pre-hydrolysis) 0.41 ± 0.01 0.21 ± 0.02 0.04 ± 0.01 0.79 ± 0.02 0.06 ± 0.01 
P+9 (pre-hydrolysis) 0.41 ± 0.01 0.47 ± 0.01 0.07 ± 0.01 0.53 ± 0.01 0.23 ± 0.01 
P+30 (pre-hydrolysis) 0.47 ± 0.01 0.61 ± 0.01 0.10 ± 0.01 0.39 ± 0.01 0.33 ± 0.01 
 
Dissociation rate constants were obtained from the 3-exponential (for P+0 post-hydrolysis) or 
2-exponential (for pre-hydrolysis traces) fit of the traces shown in Figures 4.13 and 4.14. Errors 
are SEM of the fit. kavg is the average rage of dissociation calculated from the apparent rates. 
The vastly slower rate of dissociation measured by chase experiments, in comparison to the 
kOFF obtained from the binding experiments, suggests that there may be an additional step 
following binding that makes ArfB more stably bound to the ribosome. We call this potential 
step “engagement”, and the following designed experiments are aimed at understanding the 




4.3 ArfB binding to the ribosome is tight and stable 
4.3.1 Affinity of ArfB for P+n complexes 
If there is indeed an engagement step as the measured ArfB dissociation rates indicate (see 
section 4.2.7), we would expect the overall affinity constant Kd to differ from the number 
calculated by the kOFF/kON of initial binding (see sections 4.2.4 and 4.2.5). Therefore, we turned 
to steady-state measurements of ArfB binding. Using the FRET pair described above, we 
titrated P+0(Flu) (2 nM) with sub-stoichiometric amounts of quencher-labeled ArfBGAQ(K96C) 
in the fluorimeter, recording the fluorescence intensity at each ArfB concentration until the 
binding curve reached saturation. The resulting curve was fit with a quadratic equation to 
account for ligand depletion. Because relative fluorescence (calculated as 𝑌 =
𝑌𝑛
𝑌0
, where 𝑌𝑛 is 
the fluorescence intensity at concentration 𝑛  of ArfB, and 𝑌0  is the starting fluorescence 
intensity) corresponds to the fraction of ArfB-bound ribosomes at that particular ArfB 
concentration, we could convert the curve to show the fraction of ArfB-bound ribosomes with 
the equation 𝑌′ = 𝑌 + (−1) + 1 , where 𝑌′  is the fraction of ribosomes bound, and 𝑌  is 
relative fluorescence. The curve fit gives a Kd of 4.3 ± 0.7 nM, an affinity 40 times higher than 
that calculated from the initial binding experiments (Figure 4.16a). The affinity of ArfB to P+9 






Figure 4.16. ArfB binds tightly to stalled ribosomes. Affinity of ArfB for P+0 complexes. 
Quencher-labeled ArfBGAQ(K96C) was titrated into (a) P+0(Flu), (b) P+9(Flu), and (c) P+30(Flu) 
(2 nM) and the fluorescence change recorded. Binding curves were fit with a quadratic 
equation. Error bars represent the SEM of three independent experiments. 
Due to the high affinity of ArfB for stalled ribosomes, our FRET-based affinity measurements 
were performed at low concentrations. To verify our findings, we also performed anisotropy-
based affinity titrations using single-cysteine variants labeled with fluorescein (Lakowicz, 1988) 
(Figure 4.17a). The rotational freedom of the dye decreases upon ArfB binding to the 






Figure 4.17. Anisotropy change reports on ArfB binding to the ribosome. (a) Schematic of 
anisotropy-based ArfB binding experiments. Fluorescein-labeled ArfB(K96C) is mixed with P+n 
complexes, and the anisotropy of the dye is recorded. (b) Anisotropy of the dye on ArfB 
increases upon binding to the ribosome. Fluorescein-labeled ArfB(K96C) and ArfB(R112C) (10 
nM) were mixed with excess P+0 complex (30 nM). Error bars represent the SEM of three 
independent experiments.  
Fluorescein-labeled ArfB(K96C) and ArfB(R112C) (10 nM) were titrated with unlabeled P+0 
and P+12 complexes in the fluorimeter (Figure 4.18a and Figure 4.18b). The resulting curve 
was fit with a hyperbolic equation. For P+0 complexes, the Kd values are 2.9 ± 0.7 nM and 1.3 
± 0.3 nM for ArfB(K96C) and ArfB(R112C), respectively. For P+30 complexes, the Kd values are 
2.3 ± 0.8 nM and 6.5 ± 1.9 nM for ArfB(K96C) and ArfB(R112C), respectively. Finally, to ensure 
that the affinity constant we measure is exclusively that of pre-hydrolysis complexes, we 
repeated the anisotropy-based titration using fluorescein-labeled ArfBGAQ(K96C) (Figure 4.18). 
Our titrations with P+0, P+9, and P+30 complexes yield Kd values of 1.8 ± 0.3 nM, 2.3 ± 0.3 nM, 
and 8.3 ± 0.8 nM, respectively. The Kd values obtained from these titrations are 20 to 50 fold 
lower than the Kd values calculated as kOFF/kON as described in section 4.2.4, indicating that 
subsequent steps following initial binding stabilize ArfB on the stalled ribosome. A comparison 
of Kd values calculated from initial binding experiments and measured by FRET and anisotropy 





Figure 4.18. ArfB binds tightly to stalled ribosomes. (a) Affinity of ArfB for P+0 complexes. 
ArfB(K96C) (10 nM) and ArfB(R112C) (10 nM) were titrated with P+0. (b) Affinity of ArfB for 
P+12 complexes. ArfB(K96C) (10 nM) and ArfB(R112C) (10 nM) were titrated with P+12 
complexes. (c) Affinity of ArfBGAQ for P+0, P+9, and P+30 complexes. ArfBGAQ(K96C) (10 nM) 
was titrated with P+n complexes. All single-cysteine ArfB variants were labeled with 
fluorescein. The anisotropy change at each ribosome concentration was recorded; binding 
curves were fit with hyperbolic equations, and error bars represent the SEM of three 
independent experiments. 
Table 4.5. Affinity constants of ArfB for stalled ribosomes 
 P+0 P+9 P+30 
Kd (kOFF/kON), nM 230 ± 50 470  ± 60 400 ± 60 
Kd (FRET), nM 4.3 ± 0.7 13.2 ± 2.4 17.8 ± 1.3 
Kd (anisotropy), nM 1.8 ± 0.2 2.3 ± 0.3 8.3 ± 0.8 
 
Apparent rates were obtained by exponential fitting of dissociation traces. Average rates were 






4.3.2 Effect of buffer ionic strength on ArfB binding 
The C-terminal tail of ArfB consists of several positively charged residues, and it is likely that 
its strong interactions with the ribosome are primarily mediated by electrostatic interactions. 
To test whether the tight binding of ArfB to the ribosome is mainly due to strong electrostatic 
interactions, we measured anisotropy change at increased potassium chloride concentrations 
(Figure 4.19a). The resulting dose-response curve shows that the interactions between ArfB 
and the ribosome are indeed electrostatic, however the IC50 or half-maximal inhibitory 
concentration of approximately 260 mM KCl exceeds the cellular concentration of potassium 
(180 – 200 mM, (Cayley et al., 1991)), indicating that these interactions are stable under 
physiological conditions. 
As divalent salt concentration is an important factor in ribosome dynamics (Rodnina et al., 
2011), we also titrated ArfB-bound P+0 and P+9 complexes with MgCl2 and recorded 
anisotropy change (Figure 4.19b). The IC50 is approximately 40 mM and 30 mM for P+0 and 
P+9 complexes, respectively. 
 
Figure 4.19. ArfB binding remains stable at high salt concentration. (a) Effect of monovalent 
salt on ArfB binding. ArfBGAQ(K96C) (50 nM) bound to P+0 (150 nM) was titrated with KCl. (b) 
Effect of divalent salt on ArfB binding. ArfBGAQ(K96C) (50 nM) bound to P+0 complex or P+9 
complex (150 nM) was titrated with MgCl2. Grey boxes indicate cellular salt concentrations 
(Cayley et al., 1991). The ArfB variants were labeled with fluorescein. The curves were fit with 
a dose-response equation and error bars represent the SEM of three independent 
experiments. 
These very high affinity constants show that despite initially labile interactions with the 
ribosome shown by our binding experiments (see sections 4.2.4 and 4.2.5), engagement 




that the interactions between ArfB and stalled ribosomes is specific. It also gives us reason to 
think that under physiological conditions (Cayley et al., 1991) this interaction is as strong as 





4.4 Peptidyl-tRNA hydrolysis 
Moving further along the pathway of ArfB-mediated ribosome rescue, we measured the 
apparent rate of peptidyl-tRNA hydrolysis by rapidly mixing ArfB and P+0 and P+9 complexes 
in the quenched flow at 37°C. 
4.4.1 Rates of single-round hydrolysis 
We titrated excess ArfB over P+0 complexes. At lower ArfB concentrations (up to 0.6 µM), the 
curves can be described with two exponents, while at higher concentrations the curve can be 
described with one exponent (Figure 4.20a). The rate of the first phase is 0.15 ± 0.01 s-1 and 
does not show a dependence on ArfB concentration, (Figure 4.20b). The two exponential 
behavior is likely due to non-pseudo first order conditions, with the second exponent 
describing the second round of hydrolysis (Figure 4.20c). 
 
Figure 4.20. ArfB-mediated hydrolysis on P+0 complexes. (a) Time courses of peptidyl-tRNA 
hydrolysis upon rapidly mixing ArfB (0.2-2 µM) with P+0 complexes (0.15 µM). (b) The first 
apparent rate of hydrolysis at different ArfB concentrations. The rates were obtained by fitting 
the time courses with an exponential equation. (c) Amplitudes of the first phase, calculated 
from the exponential fit of hydrolysis time courses, plotted against ArfB concentration.  Error 




To determine whether the hydrolysis rate previously measured for P+9 complexes (Figure 
4.21b) is also concentration-independent, we performed the same experiment titrating 
increasing concentrations of ArfB over P+9 complexes (Figure 4.21a). We observe a 
concentration-independent rate of hydrolysis on P+9 complexes of 0.06 ± 0.01 s-1 (Figure 
4.21b). 
 
Figure 4.21. ArfB-mediated hydrolysis on P+9 complexes is slow. (a) Time courses of peptidyl-
tRNA hydrolysis upon rapidly mixing ArfB (0.2-2 µM) with P+9 complexes (0.15 µM). Error bars 
represent the range of values of two independent experiments. (b) The first apparent rate of 
hydrolysis at different ArfB concentrations. The rates were obtained by fitting the time courses 
with an exponential equation. Error bars indicate the error of the fit. 
4.4.2 ArfB-mediated hydrolysis is pH-independent 
The apparent rate of hydrolysis is slow compared to published values of up to 10 s-1 for 
canonical release factors RF1 and RF2 (Kuhlenkoetter et al., 2011; Pierson et al., 2016). It is 
possible that instead of the catalytic step, we are measuring the preceding, rate-limiting step. 
Peptidyl-tRNA hydrolysis has previously shown to be highly pH-dependent (Indrisiunaite et al., 
2015; Kuhlenkoetter et al., 2011); therefore, we performed single-round hydrolysis 
experiments at pH 7.8, 7.4, and 8.0 for both P+0 and P+9 complexes (Figure 4.22a and Figure 
4.22b). We find that on both complexes, the hydrolysis rate is identical at all three tested pH 
levels. We can therefore conclude that with this experiment we determine the rate of a 
preceding rate-limiting step, which we hypothesize is the engagement step (Figure 4.22c). We 
further speculate that the different rates for P+0 and P+9 indicate that the engagement step 





Figure 4.22. ArfB-mediated peptidyl-tRNA hydrolysis is pH-independent. Time courses of 
peptidyl-tRNA hydrolysis upon rapidly mixing ArfB (1 µM) with (a) P+0 complexes and (b) P+9 
complexes (0.15 µM), at pH = 6.8, 7.4, and 8.0. The time courses were fit with a one 
exponential equation. (c) Comparison of the rate-limiting step on P+0 and P+9 complexes. 
Average rates were obtained from the exponential fit of single-round hydrolysis time courses. 




4.5 Structural studies of ArfB 
According to our dynamic model of initial binding, the N-terminal domain of ArfB is able to 
bind in the A site while the C-terminal tail folds and binds in the mRNA entry channel during 
the following engagement step. Previously, it was suggested that the C-terminal tail positions 
the N-terminal domain through the long flexible linker (Gagnon et al., 2012); no evidence has 
yet been presented. There is also evidence that the C-terminal tail is essential for ribosome 
binding and for peptidyl-tRNA hydrolysis. It is however unclear how the binding and folding of 
the C-terminal tail activates ArfB. 
4.5.1 Interplay of two ArfB domains 
Using the isolated N-terminal domain ArfBNterm, we measured the hydrolytic activity in the 
absence of the C-terminal tail (Figure 4.23a). In a hydrolysis assay where P+0 complexes were 
mixed with ArfB and incubated for five min at 37°C, ArfBNterm shows no hydrolytic activity. In 
the stopped flow, we observed no fluorescence change upon mixing quencher-labeled 
ArfBNterm(K96C) (ArfBNterm labeled with ATTO-540Q at position 96) with P+0(Flu) (Figure 4.23b), 
indicating that this truncated form of ArfB does not bind to the ribosome.  
We then studied binding of the isolated C-terminal domain ArfBCterm; we observe 
approximately 5% fluorescence change upon mixing quencher-labeled ArfBCterm(R112C) 
(ArfBCterm labeled with ATTO-540Q at position 112) with P+0(Flu) complexes (Figure 4.23c, 
orange trace), and three-exponential fitting of the binding trace shows that a majority of the 
truncated ArfB molecules bind to the ribosome with an apparent rate of 340 ± 20 s-1. In 
comparison, the same concentration of full-length ArfBGAQ(R112C) binds to P+0(Flu) with an 
apparent rate of 190 ± 10 s-1 (Figure 4.23c, green trace), but with a 30% fluorescence change. 
The different amplitudes of fluorescence change suggests that the binding site of the isolated 
ArfB C-terminal tail is different from that of full-length ArfB. Our biochemical experiments with 
individual domains do not provide much insight into the role of each domain in binding and 
engagement. We therefore turned to cryo-electron microscopy with the hopes of capturing 






Figure 4.23. Both ArfB domains are essential for binding and hydrolysis. (a) The N-terminal 
domain of ArfB does not show hydrolytic activity. ArfBNterm (1 µM) was incubated with P+0, 
P+9, and P+30 (0.1 µM) for 5 min at 37°C. (b) ArfBNterm does not bind to stalled ribosomes. 
ArfBNterm(K96C) (0.1 µM and 0.5 µM) was rapidly mixed with P+0(Flu) complexes (0.015 µM) 
in the stopped flow. (c) ArfBCterm(540Q) binds to stalled ribosomes in an unspecified position. 
Truncated ArfBCterm(R112C) (0.1 µM) and full-length ArfBGAQ(R112C) was rapidly mixed with 
P+0(Flu) in the stopped flow. All ArfB variants were labeled with the quencher ATTO-540Q, 
and all stopped flow experiments were performed at 20°C. 
4.5.2 Secondary structure of the ArfB C-terminal tail 
Transient secondary structures in intrinsically disordered regions have been shown to affect 
the rate of protein binding (Arai et al., 2015; Iesmantavicius et al., 2014). To detect the 
presence of secondary structures in the C-terminal tail of ArfB in solution, we measured the 
circular dichroism spectra of full-length ArfB and the ArfB N-terminal domain. We find that at 
20°C, the negative elipticity at 208 nm is slightly more pronounced for ArfB than for ArfBNterm 
(Figure 4.24a). The difference is no longer observed at 37°C (Figure 4.24b). While these results 
are still preliminary, they hint at some residual α-helicity of the ArfB C-terminal tail in solution; 
the observation that the same is not seen at a higher temperature could be due to increased 





Figure 4.24. Residual helicity of the ArfB C-terminal tail in solution. (a) Circular dichroism 
spectra of ArfB (8 µM) and ArfBNterm (8 µM) at 20°C. (b) Circular dichroism spectra of ArfB (8 
µM) and ArfBNterm (8 µM) at 37°C. Solid lines represent averaged spectra from three 
independent experiments. 
Based on this and the NMR ensemble structures, we hypothesize that ArfB assumes various 
conformations in solution, including different orientations of the disordered C-terminal tail, 
as well as conformations where the C-terminal tail is at least partially folded into an α-helix. 
These different conformations may bind to the ribosome at varying rates, explaining the 
different binding rates we observe in experiments described in section 4.2.4. However, 
whether the residual helicity of the ArfB C-terminal tail accelerates or decelerates binding 
remains unclear. 
4.5.3 Biochemical basis for structural analysis of ArfB 
Our kinetic data suggests that the interactions between ArfB and the ribosome are highly 
dynamic, which makes cryo-electron microscopy the most appropriate method for structural 
analysis, due to its ability to capture dynamic intermediates of protein complexes (reviewed 
in (Nogales and Scheres, 2015)). To stabilize ArfB on the ribosome, we incubated ArfB with 
stalled ribosomes in the presence of the apidaecin derivative Api137. Apidaecin is an 
antimicrobial peptide that binds to the peptide exit tunnel of post-hydrolysis ribosomes, and 
by forming interactions with the release factors, traps release factors on the ribosome (Florin 
et al., 2017). In single-round hydrolysis assays, where ArfB and P+0 were incubated with 
Api137, apidaecin does not impede ArfB-mediated peptidyl-tRNA hydrolysis (Figure 4.25a). 
However, we find that under turnover conditions of ArfB, P+0, and Api137, ArfB does not 




presence of Api137, ArfB remains bound to the post-hydrolysis ribosome and does not 
dissociate. 
 
Figure 4.25. Apidaecin traps ArfB on the post-hydrolysis ribosome. (a) Apidaecin does not 
affect single-round ArfB-mediated peptidyl-tRNA hydrolysis. ArfB (1 µM) was incubated with 
P+0 complexes (0.1 µM) for 5 min at 37°C in the presence of Api137 (1 µM) (b) Apidaecin 
represses ArfB turnover. ArfB (0.02 µM) was incubated with P+0 complexes (0.2 µM) in the 
presence of Api137 (1 µM). Solid lines represent the linear fit of the time course, and error 
bars represent the SEM of three independent experiments.  
Finally, to ensure that incubation with ArfB does not cause mRNA cleavage, we incubated ArfB 
with P+36 complexes that are labeled on the 3’ end of mRNA with fluorescein (provided by 
Bee-Zen Peng). We measured the anisotropy of the dye before and after 10 min incubation at 
37°C, which showed no significant difference (Figure 4.26). This shows that mRNA remains 
intact following the incubation with ArfB. 
 
Figure 4.26. ArfB binding does not induce mRNA cleavage. Anisotropy values of the fluorescein 
dye attached to the 3’ end of mRNA, before and after ArfB (0.1 µM) is incubated with P+36 





4.5.4 High resolution structures of ArfB bound to stalled ribosomes 
Cryo-EM studies were done in collaboration with Niels Fischer and Valentyn Petrychenko 
(Department of Structural Dynamics, Max Planck Institute for Biophysical Chemistry), as well 
as Daniel Wilson and Claudia Müller (Institute for Biochemistry and Molecular Biology, 
University of Hamburg). 
We obtained a 3.2 Å structure of ArfB bound to the P+0 complex (200,000 particles) (Figure 
4.27a), and a 2.6 Å structure of the P+9 complex (282,252 particles) (Figure 4.27b). The P+9 
complex sample also yielded structures of the pre-hydrolysis stalled complex with no ArfB 
bound (3.1 Å, 23,340 particles) (Figure 4.27c), as well as the post-hydrolysis ribosome with the 
tRNA in the hybrid state (3.2 Å, 25,347 particles) (Figure 4.27d).  
 
Figure 4.27. Cryo-EM structures of ArfB-bound stalled ribosomes. (a) ArfB bound to P+0 
complex. Resolution 3.2 Å with 200,000 particles. (b) ArfB bound to P+9 complex. Resolution 
2.6 Å with 282,252 particles. (c) The pre-hydrolysis P+9 complex, 3.1 Å with 23,340 particles. 
(d) The post-hydrolysis P+9 complex, 3.2 Å with 25, 347 particles. The data on ArfB-bound P+0 
complex were collected by Claudia Müller, those with P+9 complexes by Niels Fischer. Data 
analysis and model construction was performed by Niels Fischer, Valentyn Petrychenko, and 
Claudia Müller. Figure adapted from images provided by Niels Fischer. 
The high resolution of the P+9 structure yielded densities for the side chains of highly 
conserved residues in the linker region and in the C-terminal tail, allowing us to identify 
specific interactions between ArfB and the ribosome (Figure 4.28). These interactions 
correspond to functionally important residues identified in a previously published mutational 
analysis (Kogure et al., 2014). In the decoding center, Thr 108 interacts with C1493, while Arg 
105 interacts with A1409. Leu 119 stacks with G530. In the C-terminal tail, positively charged 
residues interact with the negatively charged inner face of the mRNA entry channel. 
Interestingly, in the ArfB-bound structure of the P+9 complex, the mRNA downstream of the 




(Figure 4.26), this suggests that the mRNA is unstructured when the C-terminal tail of ArfB is 
bound in the mRNA entry channel. 
 
Figure 4.28. Specific interactions between ArfB (red) and the ribosome (grey). Key interactions 
at (a) the C-terminal end of the linker region, (b) the N-terminal portion of the C-terminal tail, 
and (c) the C-terminal portion of the C-terminal tail. Figure adapted from images provided by 
Niels Fischer. 
4.5.5 A dynamic model of ArfB binding 
Using the ArfB N-terminal domain in our structures as a reference position, we superimposed 
the NMR ensemble structure of ArfB (Kogure et al., 2014) (PDB 2RTX) on the P+9 complex 
(Figure 4.29a). In this solution structure, the N-terminal domain is folded, whereas the C-
terminal tail is unstructured and extends in various directions. We find that certain 
orientations of the unstructured C-terminal tail can occupy the intersubunit space of the P+9 
complex, and appear able to avoid steric clashes with the P site tRNA with minimal 
adjustments (Figure 4.29b). This is a model of the initial encounter complex of ArfB and the 
ribosome, and it provides a possible structure for our kinetic model of multiple initial binding 







Figure 4.29. Model of the ArfB-ribosome initial encounter complex. (a) The solution structure 
of ArfB (NMR ensemble, PDB 2RTX) was superimposed on the pre-hydrolysis P+9 complex, 
using the Api137-trapped ArfB N-terminal domain as a reference position. (b) Unbound ArfB 
superimposed on the pre-hydrolysis P+9 complex shows that certain orientations of the ArfB 
C-terminal tail can occupy the intersubunit space without folding in the mRNA entry channel. 





4.6 Towards studying ArfB in the cellular context 
4.6.1 Mass spectrometry analysis of endogenous ArfB  
The GGQ motif in the N-terminal domain is responsible for the hydrolytic activity of ArfB. The 
same motif is responsible for the peptidyl-tRNA hydrolysis activity of RF1 and RF2 (Korostelev, 
2011). Methylation of the Gln in the GGQ motif has been shown to increase the rate of 
hydrolysis (Pierson et al., 2016) in RF1 and RF2. We therefore used mass spectrometry to 
determine whether the GGQ motif of ArfB is also methylated in vivo. Using the pKOV plasmid-
based gene replacement system (Link et al., 1997), we generated an E. coli strain where 
chromosomally encoded ArfB has a 3xFLAG tag appended to the N terminus. Using this strain 
we were able to pull down endogenous ArfB and analyze it by targeted mass spectrometry. 
 
Figure 4.30. Elution profile of the GGQ-containing peptide. The dotted line represents the time 
point at which MS/MS acquisition of the peptide of interest was triggered; delta mass is the 
difference between measured and predicted mass of the intact peptide, and the ion dot 
product is the vector product of the measured and theoretical isotope pattern of the peptide. 
The expected elution time window of the methylated form of the peptide is indicated in red. 
We proteolyzed ArfB with ArgC in order to obtain a peptide containing the GGQ motif, and 
analyzed the peptides with data-dependent acquisition mass spectrometry. The non-
methylated form of the peptide of interest was unambiguously identified by its MS/MS 
spectrum (data not shown) and its accurate precursor ion masses. The extracted ion 
chromatogram of the precursor ion pattern has an ion dot product of 0.98, and the delta mass 




for our peptide of interest. Given that methylation of the GGQ motif should change the 
hydrophobicity of the peptide while not affecting its charge, we looked for a peak in the 
expected retention time window within the dynamic range of the mass spectrometer, and did 
not detect a potential methylated form of the peptide (Figure 4.30). This indicates that the 






5.1 ArfB is a specialized rescue factor for non-stop stalled ribosomes 
ArfB is one of three rescue systems found in E. coli, but it cannot compensate for the loss of 
the tmRNA-SmpB and ArfA rescue systems; previous studies have shown that ArfB must be 
overexpressed in order to overcome the synthetic lethality of ΔssrA ΔarfA (Chadani et al., 
2011b). ArfB is however highly conserved in approximately 30% of the annotated bacterial 
genomes (Keiler, 2015), which led to the hypothesis that it serves as a rescue factor for more 
than non-stop stalled ribosomes. In previous studies the PURE system was used to show that 
ArfB hydrolyzes peptidyl-tRNA on ribosomes stalled on rare codon clusters (Handa et al., 2011); 
the PURE system is a mixture of transcription and translation factors, so that transcription 
from a DNA template and translation occur in parallel. These studies used NuPAGE gels to 
differentiate between released peptides and peptidyl-tRNA and therefore show only the 
endpoint of the reaction. 
Using our system of purified stalled ribosomes, we were able to perform pre-steady state 
experiments and measure the apparent rate of ArfB-mediated peptidyl-tRNA hydrolysis. As 
our results in Figure 4.2 show, the presence of more than 6 nucleotides past the ribosomal P 
site dramatically decreases the apparent rate of hydrolysis. This is one argument against 
ribosomes stalled on rare codon clusters as a substrate for ArfB, however it also does not 
invalidate previous findings. Our experiments show that given enough time, ArfB will fully 
hydrolyze peptidyl-tRNA on ribosomes stalled in the middle of mRNA; the biological 
significance of experiments performed in time frames non compatible with the life cycle of 
bacteria is however questionable. 
The slow rate of hydrolysis on P+n (n > 6) complexes raise an interesting question regarding 
the cellular context of these events. How does these very slow rates measure up to the parallel 
processes that can take place on a ribosome with a vacant A site? Our competition 
experiments show that the presence of cognate ternary complex (EF-Tu-GTP-aminoacyl-tRNA) 
preclude ArfB from rescuing ribosomes. On P+33 complexes, which we use as a model for 
ribosomes stalled in the middle of an mRNA, even a high concentration of ArfB (2 µM) over a 
relatively long incubation period (2 min) is insufficient to release the peptide, whereas under 




We find that this competition is restricted to cognate ternary complex; as shown in Figure 4.4, 
non-cognate ternary complex does not interfere with ArfB function. It is worth noting here 
that the cellular concentration of ArfB is low: proteomic studies of E. coli under many stress 
conditions have not identified ArfB (Schmidt et al., 2016); in a single-cell proteomics study, 
only half a copy of ArfB was identified, in comparison with 25,000 copies of RF1 (Taniguchi et 
al., 2010). This suggests that under physiological conditions ArfB does not rescue ribosomes 
stalled on rare codon clusters.  
We also calculate the specificity constant kcat/KM for P+0 and P+9 complexes, based on our 
Michaelis Menten titrations. KM can be understood as an overall affinity constant for the entire 
hydrolysis pathway, whereas kcat is the turnover number that represents the number of 
catalytic events per reaction time. The difference in specificity between the two complexes is 
approximately 12 fold, showing that ArfB has a clear preference for ribosomes stalled on the 
3’ end of truncated mRNAs. 
Our data conclusively show that ribosomes stalled in the middle of mRNA are not substrates 
for ArfB-mediated rescue; however ArfB might still be indirectly involved in resolving these 
complexes. A class of mRNA interferases, endonucleases that target specific mRNA sequences, 
bind to translating ribosomes and cleave the associated mRNA (Lalaouna and Masse, 2017). 
These include the toxins RelE, YoeB, YafO, YafQ, and HigB, which are activated under stress 
conditions such as heat shock and amino acid starvation (reviewed in (Starosta et al., 2014)). 
In the absence of cognate ternary complex, the toxin binds to the ribosome and cleaves the 
mRNA in the A site, generating shorter overhangs of mRNA extending past the P site, and 
creating a more ideal substrate for ArfB. In this way, ArfB may act in concert with mRNA 
interferases to resolve ribosome stalling during the translational stress response. 
5.2 Initial binding 
To understand how ArfB discriminates between ribosomes stalled on different lengths of 
mRNA, we first used FRET-based pre-steady state experiments to observe binding of ArfB to 
the ribosome. At high T °, we observe a very rapid bimolecular association reaction, with part 
of the reaction taking place in the dead time of the stopped flow (1-1.5 ms). At lower T°, kON 
calculated from the linear dependence of the apparent rate of the first exponent was 
approximately 500 µM-1 s-1, or 5 x 108 M-1 s-1. The diffusion-limited association rate of two 




computed by Valentyn Petrychenko using the cryo-EM structure and HYDROPRO) is 
approximately 8.8 x 109 according to the encounter frequency equation (Fersht, 1999). This 
suggests that a portion of ArfB in solution is optimally oriented for binding, and for this portion 
the rate of association is diffusion-limited. The remaining ArfB molecules require multiple 
attempts to bind, thus lowering the overall binding rate. 
One of the factors that increases the kON to the diffusion limit is electrostatic steering, where 
opposite charges of a protein and its binding partner attract and enhance the association rate 
(Schreiber and Fersht, 1996; Wendt et al., 1997). In our binding experiments performed with 
added Mg2+, we find that the rate of initial binding is not significantly decreased, and Mg2+ 
concentrations of up to 30 mM do not abolish the binding altogether. In comparison, IF3 binds 
with a diffusion-limited rate to the large ribosomal subunit, in addition to its canonical binding 
site on the small subunit during initiation, but this interaction is abolished at 30 mM Mg2+ 
(Goyal et al., 2017). This indicates that unlike IF3, the fast binding of ArfB is not primarily the 
result of electrostatic interactions, and the structural flexibility of the C-terminal tail giving rise 
to orientations favorable to binding may be a more important factor. 
Upon closer examination of the binding traces, we find that the second and third apparent 
rate constants also follow a linear dependence on ArfB concentration. Rather than 
conformational changes that follow initial binding, the exponential fits of our complex binding 
traces seem to show several binding events that occur in parallel, with kON values ranging from 
500 µM-1 s-1 to 1 µM-1 s-1. Judging from the amplitude of each exponent, a large proportion of 
ArfB molecules associate with the ribosome with the fastest kON. It should be noted here that 
it is highly probable that there are more than three binding modes in this binding experiment. 
A three-exponential fit is the simplest model with which we can describe our binding traces; 
fitting with more exponents will likely result in a better fit, and reveal more bimolecular 
association reactions occurring in parallel. 
An explanation for this phenomenon may lie in the intrinsic disorder of the ArfB C-terminal 
tail. The NMR ensemble structure of ArfB (PDB 2RTX, (Kogure et al., 2014)) shows that the C-
terminal tail assumes multiple orientations in solution (Handa et al., 2010); our circular 
dichroism measurements indicate that in a population of ArfB in solution, the C-terminal tail 
is at least partially helical. These different orientations and conformations of the C-terminal 




structural flexibility of intrinsically disordered protein regions increases the rate of binding, 
because there are fewer steric constraints (Shoemaker et al., 2000). However, some 
intrinsically proteins have also been shown to bind faster when transient secondary structures 
are stabilized (Arai et al., 2015; Iesmantavicius et al., 2014). Further studies are required to 
understand the contributions of intrinsic disorder and of transient secondary structures to the 
initial binding of ArfB to the ribosome. 
In addition to the kON value, the linear dependence of the apparent rate constants on ArfB 
concentration also gives us a dissociation rate constant kOFF, which is obtained from the y-
intercept of the linear fit. For the first binding step, the kOFF is approximately 100 s-1. The rapid 
association coupled with fast dissociation suggests a scanning mechanism, wherein ArfB forms 
transient interactions with ribosomes with no tRNA in the A site. The fast rate of scanning 
would suggest that it occurs independently of mRNA length, which is indeed what we observe 
in binding experiments with P+9 and P+30 complexes. As shown in Figure 4.12, the kON values 
for ArfB binding to P+9 and to P+30 complexes are comparable to that of P+0 complexes, 
indicating that substrate discrimination does not occur in the first, transient binding step, and 
suggesting the presence of a subsequent step in which ArfB assumes its catalytically active 
conformation. 
Using our high-resolution cryo-EM structures of ArfB on the stalled ribosome, we could 
superimpose the NMR ensemble structure (Kogure et al., 2014) on the stalled ribosome. As 
shown in Figure 4.29, some orientations of the ArfB C-terminal tail are able to occupy the 
intersubunit space in the disordered state, while the N-terminal domain of ArfB binds to the 
large subunit in a near-active state. This provides us with a structural model of the initial 
capture complex predicted by our kinetic studies of the initial binding step. The various 
orientations with which ArfB can bind to the ribosome could reflect the multiple bimolecular 
association reactions we observe in our binding experiments. Furthermore, the C-terminal tail 
does not bind in the mRNA entry channel at this step, which explains why the rate of initial 
binding is independent of mRNA length. 
This dynamic model of the initial capture complex also points to the existence of a 
conformational change step following initial binding. The previously published crystal 
structure (Gagnon et al., 2012) and our own cryo-EM structures show that in its active state, 




binding of the C-terminal tail could be the step in which ArfB becomes “engaged” and 
catalytically active on the ribosome. 
5.3 A slow, rate-limiting engagement step 
Our observations of initial binding suggest that ArfB undergoes an engagement step after 
initial binding to assume its active state on the stalled ribosome. Evidence of this step can be 
found in chase experiments described in section 4.2.7, where dissociation of ArfB is directly 
monitored after a period of incubation with stalled ribosomes.  
The two exponential traces that describe ArfB dissociation suggest that there is a fast-
dissociating population of ArfB for which the kOFF is approximately 0.4 s-1, and a slow-
dissociating population for which the kOFF is approximately 0.02 s-1. This could be because we 
monitor ArfB dissociating from various bound states on the ribosome, or because of 
heterogeneity in the sample; we therefore report the average dissociation rates in Table 4.4. 
Regardless of mRNA length, and dissociation rates for P+0, P+9, and P+30 are several orders 
of magnitude slower than the respective kOFF values calculated from the initial binding 
experiment (Table 4.3). This indicates that in this experiment we monitor ArfB dissociation 
after engagement, and not from the initial encounter complex. Additionally, our FRET-based 
and anisotropy-based affinity titrations show that ArfB has an affinity for the ribosome in the 
nanomolar range, while the affinity constant calculated as kOFF/kON from the initial binding 
experiments is 20 to 50 fold larger (Table 4.5). Together, these data support the existence of 
an engagement step following initial binding that stabilizes ArfB on the ribosome.  
While the initial binding step is not governed by electrostatic interactions, after the 
engagement step, the interaction between ArfB and the ribosome is mediated by strong 
electrostatic interactions that can be disrupted by high concentrations of monovalent and 
divalent salt, as shown by the titrations described in section 4.3.2. This suggests that during 
the engagement step, strong electrostatic interactions between ArfB and the ribosome are 
established that are stable at physiological salt concentrations. 
Our high resolution structures of ArfB bound to the ribosome show a network of such specific 
interactions between the ribosome and the linker region and C-terminal tail of ArfB, as shown 
in Figure 4.28. These interactions include Arg residues at positions 105, 118, 132, Lys residues 




crystal structure (Gagnon et al., 2012). The positively charged amino acids interact with 
negatively charged groups on 16S rRNA, with the exception of Arg 105, which interacts with 
23S rRNA. These residues were all previously found to be essential for ArfB activity (Kogure et 
al., 2014). We propose that these crucial interactions are established during the engagement 
step and stabilize ArfB binding. However, how these interactions affect the position of the N-
terminal domain and activate ArfB-mediated peptidyl-tRNA hydrolysis is still unclear. 
5.4 Engagement as the substrate discrimination step 
Our single-round hydrolysis experiments show that the apparent rate of ArfB-mediated 
peptidyl-tRNA hydrolysis is approximately 0.15 s-1 on P+0 complexes, which is very slow 
compared to the rate of canonical release by RF1 and RF2 at approximately 10 s-1 
(Kuhlenkoetter et al., 2011; Zaher and Green, 2011). 
The Gln in the GGQ motif of RF1 and RF2 is methylated, a post-translational modification that 
increases the rate of hydrolysis and produces uniform rates of peptidyl-tRNA hydrolysis on all 
amino acids (Pierson et al., 2016). Using an E. coli strain with chromosomally tagged ArfB, we 
were able to immunoprecipitate endogenous ArfB for mass spectrometry analysis. The results 
summarized in Figure 4.30 show no evidence of methylation of the GGQ motif. This could be 
one contributing factor to the slow hydrolysis by ArfB. In the absence of methylation, however, 
canonical release is approximately 2 s-1 (Kuhlenkoetter et al., 2011; Zaher and Green, 2011), 
which is still faster than the ArfB-mediated reaction. 
Peptidyl-tRNA hydrolysis by RF1 and RF2 is highly pH-dependent (Indrisiunaite et al., 2015; 
Kuhlenkoetter et al., 2011). In the case of ArfB, changing the pH of the solution has no effect 
on the rate of hydrolysis on both P+0 and P+9 complexes. This leads us to conclude that in our 
single-round hydrolysis experiments, we do not monitor the catalysis step, but rather the 
preceding pH-independent engagement step.  
We can therefore directly compare the engagement step on P+0 and on P+9 complexes. For 
the latter, the pH-independent rate is 0.06 s-1; the slower engagement coupled with faster 
dissociation rate could contribute to effective substrate discrimination by ArfB. Given that the 
C-terminal tail of ArfB must fold and bind within the mRNA entry channel for ArfB to assume 
its active state, it is likely that the slow engagement on the P+9 complex involves the 




that in the cryo-EM structure of ArfB bound to the P+9 complex, the mRNA is displaced by the 
C-terminal α-helix of ArfB, and is disordered in the intersubunit space. 
5.5 Kinetic model of ArfB-mediated ribosome rescue  
The elemental rate constants of the ArfB-mediated ribosome rescue pathway can be 
summarized in the kinetic scheme below (Figure 5.1). Initial binding and dissociation from the 
initial encounter complex is fast, effectively allowing ArfB to rapidly “scan” ribosomes with an 
empty A site. We show that instead of long-range electrostatic interactions, the fast binding 
may be a feature of the intrinsic disorder of the C-terminal tail; the structural flexibility allows 
a portion of ArfB molecules to arrive in the optimal orientation for binding. 
 
Figure 5.1. Kinetic model of ArfB-mediated ribosome rescue. Cryo-EM models were provided 
by Niels Fischer and Valentyn Petrychenko. 
We observe many parallels between this binding step and published association models of 
intrinsically disordered proteins (Mollica et al., 2016; Shammas et al., 2016). One such model 
is conformational selection, in which the protein exists in an equilibrium of conformations, 
and binding to the more favorable conformation drives the equilibrium towards formation of 
the favorable conformation. Another model is one of induced fit, where fast binding is 
followed by folding and accommodation on the binding partner (Shammas et al., 2016). 
Additionally, it has been proposed that intrinsically disordered proteins have higher 
association rates due to the “fly-casting” model, wherein intrinsic disorder enables long-range, 
unspecific, and weak interactions that are strengthened as the protein folds and “reels in” its 




While there are still few kinetic studies that provide definitive experimental evidence of either 
model, our pre-steady state analysis of ArfB binding points to a combination of these proposed 
binding models. We observe multiple rates of initial binding, which suggests that ArfB is able 
to associate with the ribosome in various conformations, with some more favorable than 
others and binding more rapidly; this fits the description of the conformational selection 
model. However, the engagement step involves the folding of the C-terminal tail that activates 
ArfB-mediated hydrolysis, which is in accordance with the induced fit model. 
Engagement is the step where ArfB discriminates between ribosomes with different lengths 
of mRNA extending past the P site. On P+0 complexes, this step is where the C-terminal tail 
folds into an α-helix within the mRNA entry channel, and it occurs at a rate of 0.15 s-1. On P+9 
complexes, however, the 9 nucleotides residing in the mRNA entry channel must diffuse into 
the intersubunit space in order for the ArfB C-terminal tail to bind, resulting in an engagement 
rate of 0.06 s-1. Once engagement occurs, peptidyl-tRNA hydrolysis is carried out by the GGQ 
motif.  
While it is still unclear how the binding of the C-terminal tail triggers peptidyl-tRNA hydrolysis, 
the network of interactions revealed by our cryo-EM structures allow us to compare the ArfB-
bound ribosome with the RF2-bound ribosome (Korostelev, 2011). In both structures, A1493 
is stacked with A1913. This is mediated by the interactions between Thr 108 of ArfB and C1493. 
While G530 takes part in stop codon recognition in RF2-catalyzed translation termination, it 
stacks with Leu 119 of ArfB. Furthermore, Arg 105 is situated approximately in the middle of 
the long flexible linker. The strong interaction of Arg 105 with A1409 observed in our cryo-EM 
structure could suggest a role in orienting the C-terminal domain after initial binding. 
ArfB dissociates from the post-hydrolysis ribosome with an average rate of approximately 0.4 
s-1. The kcat of the entire reaction is 0.01 s-1, indicating that turnover of ArfB is limited by 
dissociation. Interestingly, our structure of ArfB bound to the post-hydrolysis P+9 complex 
shows that in the post-hydrolysis state, the strong electrostatic interactions between ArfB and 
the ribosome persist through different rotational states of the subunits. While a single-
molecule study of subunit rotation in the presence of ArfB suggested that ArfB stabilizes the 
ribosome in the rotated state (Casy et al., 2018), it is unclear if there is truly a cause-effect 
relationship, or if the change in ribosome dynamics is in fact a consequence of peptidyl-tRNA 




ribosome throughout different rotational states could be the reason why dissociation of ArfB 
from post-hydrolysis complexes is slow. 
5.6 ArfB turnover – assisted or not? 
While our model is compiled with extensive experimental data on the initial binding and 
engagement steps, less is known about post-hydrolysis dissociation. With regards to ArfB 
turnover, our Michaelis-Menten titrations yielded a kcat of 0.01 s-1, which means that an ArfB 
molecule requires 100 s for each catalytic cycle. This renders ArfB a highly inefficient enzyme 
compared to canonical release factors (Adio et al., 2018), and leads to the question whether 
ArfB dissociation is assisted by additional factors. In the case of RF1 and RF2, dissociation is 
facilitated by RF3 in a GTP-dependent manner and occurs at approximately 1 s-1 (Adio et al., 
2018; Peske et al., 2014; Zaher and Green, 2011). 
In our model system, we measured the effect of translation factors on ArfB dissociation using 
initial velocity as a readout. Under turnover conditions, the initial velocity of the reaction 
reflects how quickly each ArfB molecule dissociates and rebinds to a new substrate. We find 
that adding recycling factors RRF and EF-G caused a moderate increase in initial velocity. 
Ribosome recycling is a GTP-dependent process: RRF binds to the ribosomal A site and 
stabilizes the ribosome in the rotated state, and GTP hydrolysis by EF-G promotes subunit 
splitting (Gao et al., 2005; Peske et al., 2005).  The strongest effect is when both EF-G and RRF 
are present, but there is no clear difference between experiments done with GTP and its 
slowly-hydrolyzing analog GTP-γS. This could be because GTP-γS was still hydrolyzed during 
the course of the experiment, or because the effect is independent of GTP hydrolysis. We 
suggest that EF-G and RRF, by binding to post-hydrolysis ribosomes, effectively titrate away 
ribosomes that ArfB would otherwise scan upon dissociation. In this way the probability that 
ArfB binds to a pre-hydrolysis substrate complex is higher, therefore turnover is accelerated. 
In addition to recycling factors, HflX is another factor that promotes subunit dissociation 
(Zhang et al., 2015). Expression of HflX is a part of the bacterial stress response: hflx is encoded 
in a heat stress response operon, and growth of Δhflx strains of E. coli is slower at higher 
temperatures (Noble et al., 1993; Tsui et al., 1996). Given that our data shows ribosome 
recycling factors have an effect on ArfB turnover, the question arises as to whether HflX might 
have a similar effect. Hflx binds to the intersubunit side of the 50S subunit and interacts with 




post-termination complexes (Zhang et al., 2015). Since HflX is expressed in response to heat 
stress, it is suggested that it targets ribosomes stalled as a result of stress, which in turn are 
substrates for ArfB-mediated ribosome rescue (Coatham et al., 2016; Zhang et al., 2015). 
In unpublished data from our lab, ribosome splitting by recycling factors and by HflX appear 
to be very similar, also in the presence of ArfB. In fact, on ribosomes rescued by ArfB, the 
ribosome splitting traces for recycling factors and for HflX have the same delay, which could 
be due to ArfB dissociation. These results are however preliminary, and further experiments 
are required to make conclusions regarding whether HflX has a specific role in the ArfB-
mediated ribosome rescue pathway. Such experiments could include monitoring the rate of 
ArfB dissociation, as well as measuring the initial velocity of the hydrolysis reaction, in the 
presence of HflX. 
5.7 On the biological role of ArfB 
In investigating the ArfB rescue mechanism, we were able to conclusively show that ArfB 
preferentially rescues ribosomes when there are fewer than 6 mRNA nucleotides extending 
past the P site. We also show that ArfB turnover is slow, albeit moderately accelerated by the 
presence of ribosome recycling machinery. Our results paint a picture of a rescue factor that 
is somewhat inefficient and present at very low levels in E. coli, where more abundant and 
more efficient rescue systems exist in tmRNA-SmpB and ArfA. 
It may be the case that in E. coli, ArfB represents the very last line of defense against non-stop 
stalling, although its conservation in 30% of sequenced bacterial species remains an 
interesting aspect of its biological role (Keiler, 2015). One common method of examining the 
function of proteins is to pull-down interacting factors with immunoprecipitation; in this work, 
we established E. coli strains with chromosomally tagged ArfB that can be used to construct 
an interactome. We have also generated the same chromosomal tags on a background of 
ΔssrA to potentially compare the interactome with and without tmRNA-SmpB. Another future 
application of the tagged strains could be to purify ArfB-associated ribosomes and sequence 
the associated mRNAs, so as to assess whether ArfB targets specific transcripts for rescue. 
While the significance of ArfB in bacteria is somewhat unclear, it is known that its eukaryotic 
homologs play an important role in mitochondrial translation. The human homolog ICT1 in 




hydrolytic activity has been shown to also be essential for cell viability (Feaga et al., 2016; 
Haque and Spremulli, 2010; Richter et al., 2010). In our experimental system, purified ICT1 
(provided by Dr. Ricarda Richter-Dennerlein) is functional on stalled bacterial ribosomes; it 
shows hydrolytic activity on our P+0 complexes, while mtRF1a, a known mitochondrial release 
factor (Soleimanpour-Lichaei et al., 2007), does not (data not shown). 
Given the strong structural similarities between ArfB and ICT1 (Handa et al., 2010), it is 
tempting to speculate on the function of ICT1 based on our understanding of ArfB. The 
decoding center of mammalian mitochondrial ribosomes is similar to that of bacterial 
ribosomes, and the mRNA channel in the A site is also conserved (Greber and Ban, 2016). In 
conjunction with our findings that ICT1 functions on bacterial stalled ribosomes, this seems to 
suggest that the linker and C-terminal tail regions of ICT1 are capable of forming interactions 
with the ribosome, much like those we observe in the ArfB-bound ribosome structures. 
Furthermore, the mRNA length-dependency of hydrolytic activity should be similar despite 
the differences between mitochondrial and bacterial ribosomes. The C-terminal tail of ICT1 is 
also very positively charged, and key residues of the ArfB C-terminal tail, identified in our cryo-
EM structure, are conserved (Kogure et al., 2014): namely Arg 118, 119, 132, and Lys 122 and 
129. As we show in this study, these residues take part in strong and stable interactions 
between ArfB and the bacterial mRNA entry channel, and are essential for peptidyl-tRNA 
hydrolysis. Based on these observations, it is possible that the corresponding residues on ICT1 
play a similar role. As such, the competitive inhibition of peptidyl-tRNA hydrolysis by mRNA 
extending past the P site may also apply in the case of ICT1. 
This hypothesis has two implications. The first is regarding translation termination of 
respiratory chain proteins MT-CO1 and MT-ND6. These two genes do not have in-frame stop 
codons; rather, the transcript ends with AGA and AGG, respectively (Anderson et al., 1981). 
Human mitochondria do not have the mitochondrial tRNA isoforms that recognize these 
arginine codons, and the method of termination for these proteins is unclear. It has been 
suggested that a -1 frameshift that positions a conventional stop codon UAG in the ribosomal 
A site (Temperley et al., 2010a; Temperley et al., 2010b). On the other hand, ICT1, given its 
lack of codon-recognition domains alongside its peptidyl-tRNA hydrolysis activity, represents 
another proposed termination mechanism. However, both transcripts have 5’UTR regions of 




peptide release highly inefficient, lending more credence to the theory of a -1 frameshift 
facilitating termination. 
The other implication of the mRNA length-dependence of ICT1 activity is associated with the 
regulation of mitochondrial mRNA stability. Mitochondrial mRNAs, with the sole exception of 
MT-ND6, undergo 3’ polyadenylation (Bai et al., 2011; Lapkouski and Hallberg, 2015; Tomecki 
et al., 2004). While this kind of post-transcriptional modification increases the stability of 
cellular mRNAs, its effect on mitochondrial mRNAs is transcript-specific (Nagaike et al., 2005; 
Wydro et al., 2010), and can be removed by the 2’-phosphodiesterase PDE12 (Rorbach et al., 
2011). Moreover, in seven of the open reading frames transcribed in mitochondria, 
polyadenylation completes the stop codon (Temperley et al., 2010b). In light of the findings in 
this study, we postulate that ICT1 can act when ribosomes translate transcripts that have been 
deadenylated, and in doing so act in concert with the mRNA degradasome to facilitate mRNA 
turnover. 
In addition to ICT1, C12orf65 is another mitochondrial protein that is similar to ArfB. It has 
homologous domains to RF2, and its C-terminal tail is also rich in positively-charged amino 
acids (Kogure et al., 2012). Though it has been classified as a putative release factor, hydrolytic 
activity has yet to be observed in vitro (Ayyub et al., 2020). It has so far proven very difficult 
to purify active mitochondrial ribosomes, and insights into the ArfB-mediated ribosome 
rescue pathway is the most reliable analysis of this family of peptidyl-tRNA hydrolases 
(Burroughs and Aravind, 2019; Duarte et al., 2012). 
Though their biological function is still unclear, the importance of ICT1 and C12orf65 is 
apparent. Apart from being essential for cell viability, ICT1 has also been shown to be 
differentially expressed in a number of cancers (Lao et al., 2016; Wang et al., 2017; Xie et al., 
2017). Patients with mutations in C12orf65 have presented with mitochondrial disease and 
mitochondrial protein synthesis deficiencies (Antonicka et al., 2010; Wesolowska et al., 2015). 
A detailed and comprehensive understanding of how ArfB interacts with the ribosome 
provides a basis for further studies of mitochondrial ribosome rescue. 
In this work, we present a detailed mechanistic analysis of ArfB-mediated ribosome rescue. 
We address the issue of substrate specificity, construct a kinetic model of the rescue pathway, 
and provide structural insight that supports our model. Our findings may shed light on similar 




further biophysical studies of ArfB, not only as a release factor but also as a model for the 
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7.1 Supplementary data 
Table 7.1. Summary of rate constants 
 
Table 7.2. Apparent rates of initial binding 
 
 
 P+0 P+9 P+30 
Hydrolysis rate, s-1 0.15 ± 0.01 0.06 ± 0.01 0.004 ± 0.001 
Fast kON, µM-1s-1 500 ± 60 300 ± 30 300 ± 40 
Fast kOFF, s-1 100 ± 20 140 ± 10 120 ± 10 
Medium kON, µM-1s-1 101.2 ± 10.2 84.1 ± 20.4 80.2 ± 12.9 
Medium kOFF, s-1 3.9 ± 2.5 0.78 ± 5.6 2.5 ± 3.2 
Slow kON, µM-1s-1 0.73 ± 0.04 0.06 ± 0.01 1.8 ± 0.5 
Slow kOFF, s-1 0.39 ± 0.01 0.33 ± 0.01 0.11 ± 0.14 
kdiss avg, s-1 0.06 ± 0.01 0.23 ± 0.01 0.33 ± 0.01 
KM, µM 0.25 ± 0.09 2.5 ± 1.3  
kcat, s-1 0.010 ± 0.001 0.019 ± 0.006  
  
ArfB, µM 
0.05 0.1 0.2 0.3 0.4 0.5 
P+0 
kapp1, s-1 130 ± 3 140 ± 1 220 ± 1 290 ± 2 320 ± 2 390 ± 2 
kapp2, s-1 11 ± 1 10 ± 1 30 ± 1 30 ± 1 40 ± 1 70 ± 1 
kapp3, s-1 0.4 ± 0.2 0.5 ± 0.1 0.5 ± 0.1 0.6 ± 0.1 0.7 ± 0.1 1.0 ± 0.1 
P+9 
kapp1, s-1 160 ± 3 161 ± 2 170 ± 1 220 ± 1 280 ± 1 280 ± 1 
kapp2, s-1 15 ± 1 13 ± 1 14 ± 1 23 ± 1 37 ± 1 37 ± 1 
kapp3, s-1 0.7 ± 0.1 0.5 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 
P+30 
kapp1, s-1 160 ± 3 160 ± 2 180 ± 1 200 ± 1 245 ± 1 261 ± 1 
kapp2, s-1 0.1 ± 0.2 7.0 ± 0.2 8.0 ± 0.1 13 ± 1 19 ± 1 24 ± 1 
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gún nā phah-khui sim-lāi ê mn̂g 
就會看見故鄉的田園 
tsiū ē khuànn-kìnn kòo-hiong ê tshân-hn̂g 
雖然路頭千里遠 
sui-jiân lōo-thâu tshian-lí hn̄g 
總會暫時予阮思念想欲轉 
tsóng ē tsiām-sî hōo gún su-liām siūnn-beh tńg 
故鄉故鄉今何在 
kòo-hiong, kòo-hiong kim hô-tsāi 
望你永遠在阮心內 
bāng lí íng-uán tsāi gún sim-lāi 
阮若拍開心內的門 
gún nā phah-khui sim-lāi ê mn̂g 
就會看見故鄉的田園 
tsiū ē khuànn-kìnn kòo-hiong ê tshân-hn̂g 
- Excerpt from 阮若打開心內的門窗 (1958) 
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